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ABSTRACT 
 Ultrasound contrast agents (UCAs) are tiny microbubbles used clinically to 
enhance the contrast of B-mode images. Recently, UCAs have been combined with 
therapeutic ultrasound techniques to increase their effectiveness. These therapeutic 
techniques often require high concentrations of UCAs at varying pressure amplitudes, 
which increases the risk of adverse bioeffects. Therefore, the quantification of UCA 
concentration at a target location inside the body is necessary to reduce the risk of 
unwanted bioeffects and to determine the in vivo concentration of UCAs as a result of 
their injection. In this work, a method for extracting estimates of UCA concentration 
using backscatter coefficients (BSCs) was developed and verified in vitro. Experiments 
to verify the method were performed with both UCAs and glass bead microspheres in 
degassed water using a beaker setup and a flow system setup. Experimentally obtained 
estimates of the BSC were fit to ultrasound scattering models to extract concentration 
estimates of either the UCAs or the glass beads. The fitting was accomplished with a 
Levenberg-Marquardt regression algorithm, which resulted in UCA concentration and 
size estimates. In order to verify the estimates of UCA concentration, a sample of the 
UCA and degassed water mixture was extracted after the ultrasonic data were acquired, 
and the sample was inserted into a hemacytometer. Concentration estimates with the 
hemacytometer were acquired by counting the number of UCAs in a known volume of 
the mixture. Initial experiments with the flow system and UCAs in porcine whole blood 
were also conducted. The experimental BSCs of the blood by itself were compared to a 
calculated theoretical BSC for blood, and the experimental BSCs of the UCAs in blood 
were compared to experimental BSC estimates of UCAs in water. A summary of the 
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results is as follows. First, the estimated concentration of glass beads was within 4% of 
the concentration of beads flowing through the experimental flow chamber. Next, an 
optimal peak rarefactional pressure (PRP) amplitude range of 140-390 kPa was 
determined for extracting UCA concentration estimates within one standard deviation of 
the hemacytometer based estimates and with the UCA scattering model that was used. 
Finally, future investigation must focus on improving the quantification technique with 
UCAs in blood to be able to extract accurate concentration estimates of UCAs in blood. 
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CHAPTER 1 INTRODUCTION 
1.1 Background 
Ultrasound contrast agents (UCAs) are currently used in clinical applications for 
enhanced imaging of blood perfused regions [1], [2], [3]. UCAs, microbubbles 
comprised of a gas such as air or a heavy gas such as a perfluorocarbon or nitrogen, 
are encapsulated by a shell of a different material. The gas has a much lower 
impedance than water or tissue, and so the contrast of B-mode images is enhanced. 
Heavy gases are utilized because they are less water soluble, which helps oppose the 
diffusion of the gas from the bubble, increasing the lifetime of the UCA. 
Perfluorocarbons are ideal for UCAs in the bloodstream because these gases have very 
low solubility in blood and a high vapor pressure. The shell material and thickness can 
vary based upon the desired application. For imaging purposes, the shell is often 
composed of albumin, a lipid, or a polymer with nanometer-scale thickness. 
1.2 Motivation 
While UCAs have been used for many years in diagnostic applications, they are 
not without risks. Studies both in vivo and ex vivo have been performed to validate that 
cavitation of UCAs can cause damage to surrounding cells and tissues [4], [5]. One 
early in vivo study [6] showed that inertial cavitation of UCAs during imaging damaged 
microvessels in the spinotrapezius muscle of rats. It was concluded that the level of 
damage was dependent upon the concentration of UCAs and the type of UCA used. 
Many of the ex vivo studies that evaluated the risk of negative bioeffects were 
conducted with concentrations much higher than are used clinically for imaging 
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purposes [7]. Also, most of these studies have reported that potential damage from the 
collapse of UCAs was dependent upon UCA concentration, the duration of the applied 
ultrasound, and the maximum pressure amplitude in the tissue. 
Due to their compressibility and shell properties, UCAs have been examined for 
purposes other than diagnostic imaging. Therapeutic applications such as sonoporation 
[8], [9], sonophoresis [10], angiogenesis [11], and lithotripsy [12], [13], have been 
enhanced when combined with UCAs. Recently, UCAs have also been explored as a 
means to increase the effectiveness of tissue ablation using high intensity focused 
ultrasound (HIFU) [14], [15]. However, in order to improve the effectiveness of each of 
these techniques, a high concentration of UCAs is often required at a target location in 
the body. As a result, it is probable that UCAs will be present along the ultrasound 
pathway to the transducer focus. Nishihara et al. [16] have demonstrated that the 
scattering of energy and rupture of bubbles along the pathway can cause damage and 
disrupt the focusing of the beam. Knowledge of concentration both at the transducer 
focus and along the pathway to the focus is vital for minimizing damage and for 
optimizing the effectiveness of the UCA-enhanced therapies. 
Another application of UCAs that has attracted study is their use for targeted 
drug delivery [17]. In using UCAs for targeted drug delivery, the drug is either inserted 
into the shell of the bubble or between the shell and the gas core. Once the carrier 
agents reach their desired destination, high intensity ultrasound is applied in order to 
induce inertial cavitation, releasing the drug. Eisenbrey et al. [18] showed that UCAs 
improved chemotherapeutic delivery to a liver tumor in vivo by 110%. However, it was 
difficult to control the amount of drug that was released because the concentration of 
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UCAs at the delivery site was unknown. Knowing this concentration value or devising a 
technique to provide estimates of the local UCA concentration would help to optimize 
the performance of this targeted drug delivery technique. 
Thus far, because of the difficulty of knowing the dose at a target site, little work 
has been done to establish UCA dose versus response curves for these therapeutic 
techniques. Currently, UCA concentrations are estimated by the amount of prepared 
UCA solution inserted at the injection site. Once the UCAs have entered the 
bloodstream, it is estimated that 75% are lost through diffusion and fragmentation within 
10 minutes [19]. Without proper knowledge of concentration levels at a specific site, it is 
very difficult to predict the required intensity and duration of the applied ultrasound to 
achieve a desired bioeffect. In addition, it becomes more difficult to conduct research to 
determine the optimal UCA dose for the desired bioeffects. As a result, either a 
technique could underperform or the risk of unnecessary damage and other undesirable 
bioeffects could be magnified. Therefore, it is a goal of this work to estimate UCA 
concentrations in vitro using a regression technique with the experimentally estimated 
backscatter coefficient (BSC) from UCAs, such that future work can assess the 
technique in vivo. 
Four experiments were performed to achieve this goal. First, estimates of 
backscatter were obtained for UCAs in degassed water in a beaker. An in vitro flow 
system was also developed to emulate the characteristics of the dynamic environment 
inside the body. The second experiment consisted of obtaining backscatter estimates of 
glass spheres in degassed water using the flow system in order to demonstrate that the 
setup could be used to predict accurate scattering behavior. Third, experimental 
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estimates of the BSC were also obtained for UCAs in degassed water using the flow 
system. Finally, experimental trials were performed with UCAs in porcine whole blood 
using the flow system. 
1.3 Literature review of BSC estimates with UCAs 
 In order to effectively estimate UCA concentration using backscattered 
ultrasound, it was necessary to utilize an appropriate theoretical model. The BSC is a 
powerful tool commonly used to quantify the frequency-dependent scattering of 
ultrasound incident upon a collection of scattering bodies. It is particularly useful 
because it provides a measure that is independent of system characteristics. The 
theoretical BSC was used to describe the scattering behavior of glass beads, UCAs, 
and blood. Estimates of the experimental BSC were then fit to theoretical models to 
extract concentration estimates of the UCAs and glass beads. 
 Previous estimation of the backscatter coefficient for a variety of UCAs has 
demonstrated that backscattered power which has been compensated for attenuation is 
linearly proportional to the concentration of UCAs [20], [21], [22]. This relationship was 
found to hold for a wide variety of frequencies, ranging from 1 to 30 MHz. One of these 
studies [21] found that the linear relationship held for concentrations as low as 10,000 
UCAs/mL, and another [22] found that it held for concentrations as high as 20 million 
UCAs/mL. It is important to note that this may not be the upper limit of concentration 
where the linear relationship is maintained because concentrations above 20 million 
UCAs/mL were not investigated. In addition, the linear increase in backscattered power 
with concentration suggests that multiple scattering is insignificant for concentrations as 
high as 20 million UCAs/mL. Also, concentrations of UCAs in vivo may vary by location 
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in the body and the type of injection used. For example, for clinical imaging of the heart, 
a standard 2.4 mL bolus injection would be drawn into the right ventricle within a few 
seconds, leading to concentrations greater than 20 million UCAs/mL [20]. On the other 
hand, clinical perfusion imaging often utilizes a slow, constant UCA infusion technique, 
where UCA concentrations in tissues may remain below 200,000 UCAs/mL [20]. 
 None of the above referenced UCA concentration studies estimated the absolute 
concentration of UCAs in the system based upon the resulting BSCs. Only one study 
[22] used the theoretical BSC from the linear model introduced in Section 2.3.1 to 
compare with experimental estimates. However, the concentrations of UCAs in that 
study were based upon the amounts inserted into the system, and no attempts were 
made to use experimental data to extract absolute (rather than relative) estimates. It is 
therefore a goal of this work to demonstrate that ultrasonic backscatter measurements 
can be used to estimate UCA concentrations by fitting the linear model for BSC to 
experimental estimates. 
1.4 Organization 
 The thesis is organized as follows. In Chapter 2 models for the scattering of 
ultrasound are reviewed briefly and discussed. Chapter 3 contains a description of the 
methods employed to predict accurate estimates of UCA concentration using ultrasonic 
backscatter, as well as an explanation of the simulations. The results of the simulations 
and experiments are presented in Chapter 4, and Chapter 5 contains a discussion of 
the results and suggestions for future work. 
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CHAPTER 2 THEORY 
2.1 Introduction 
 The chapter is organized as follows. Because the in vitro flow system was used 
to collect experimental BSC estimates of glass beads, the beginning of the chapter 
contains a short description of the theoretical scattering model for rigid spheres that was 
used. Next, the linear model that was used to predict UCA concentration is described 
(the de Jong model). A second model was also considered to describe the dynamics of 
UCAs that incorporates nonlinear behavior (the Marmottant model). Finally, estimates of 
the BSCs of UCAs in blood were obtained using the BSC of blood as a reference. For 
this reason, a review of the model used to predict the scattering from blood is provided 
in this chapter. 
2.2 Scattering from glass spheres 
 The theoretical scattering from spherical glass beads was used to fit 
experimental estimates of the BSC in order to obtain estimates of glass bead size and 
concentration. These two parameters can be estimated using the frequency spectrum of 
the backscattered ultrasound from a volume of glass beads. 
Briefly, the theoretical backscatter cross section for a single solid sphere (such 
as glass) can be calculated from the development introduced by Faran [23]. For the 
particular case of glass beads, the density of glass used in this work was 2.38 g/mL, the 
sound propagation speed was 5570 m/s, and the Poisson‟s ratio was 0.21. Because the 
backscatter cross section for a solid sphere is a function of both incident frequency and 
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sphere size, the characteristic size (radius) of the spheres can be determined using an 
optimization technique. The optimization technique used in this work is as follows [24]: 
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This minimum average squared deviation technique determines the estimated scatterer 
diameter (ESD) using the function Χ, which is the ratio of the experimental BSC σBSC-exp 
to the theoretical backscatter cross section of an individual solid sphere νFaran in 
decibels. In this optimization technique k is the acoustic wavenumber, R is the radius of 
the glass bead, and the over-bar for Χ denotes the mean value of Χ for all ki within the 
frequency bandwidth chosen for analysis.  
The estimated scatterer concentration (ESC) is estimated from the ESD as [25] 
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By comparing these parameters to the estimated size distribution and concentration of 
glass beads added to the system, the experimental flow system was validated for 
estimating concentrations of scattering objects. 
2.3 Theoretical BSCs of UCAs 
Two theoretical scattering models were studied to compare their behavior to 
experimental estimates. The first model was also used to develop an estimator to 
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estimate UCA concentration and was derived from the scattering cross section for a 
single UCA. The scattering cross section of an object is defined as the total acoustic 
power scattered by the object in all directions divided by the incident acoustic intensity 
[26]. In this model the UCA is assumed to oscillate linearly, and the scattering cross 
section does not depend upon the peak rarefactional pressure (PRP) amplitude of the 
incident wave.  
The second model characterizes the dynamic response of a single UCA exposed 
to ultrasound. The model does not limit the response to linear oscillations. When the 
UCA oscillates nonlinearly, it does so asymmetrically; the UCA radius may expand 
many more times its undisturbed size while it contracts much less. In this model the 
response is heavily dependent upon the incident PRP amplitude. 
2.3.1 Linear model 
The scattering cross section of a single shelled UCA, derived from that of a 
single air bubble in water [27], is described by de Jong et al. [28] as 
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where R is the resting bubble radius, fr is the bubble resonance frequency, f is the 
frequency of the incident ultrasound, and δ is a damping coefficient that includes effects 
of re-radiation, viscosity of the surrounding fluid, and heat conduction. The damping 
coefficient is 
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where k is the acoustic wavenumber based upon the sound speed of the suspending 
medium, ω is angular frequency of the applied ultrasound, ε is the dynamic viscosity of 
the surrounding fluid, and the ratio d/b is defined in [29] and includes the effects of 
thermal conductivity. The resonance frequency of the bubble is [28] 
 
3
2
4
2
pa
r
SS βb
πR ρ ρ
f
π


, (2.6) 
where Sa is the adiabatic stiffness of the gas, β is the surface tension coefficient, Sp is 
called the shell parameter [30], ρ is the density of the surrounding medium, and b is the 
inverse polytropic coefficient. The backscatter cross section for a bubble is calculated 
based upon the fraction of the surface area of the transducer, A, to the total surface 
area of a sphere with radius equal to the distance, z0, of the transducer to the scattering 
volume: 
 
2
04
bsc sc
A
σ σ
πz
 . (2.7) 
If the detected ultrasound is not significantly affected by the multiple reflections of sound 
among the UCAs, i.e. multiple scattering is minimal, then the total backscatter 
coefficient is the sum of the backscatter cross section of each UCA in the resolution cell 
divided by its volume. 
 The de Jong et al. [28] model has been applied to ultrasonic backscatter results 
in a variety of studies in order to obtain estimates for physical parameters of multiple 
UCA types [31], [32], [33]. The shell friction and shell parameter estimated by [32] and 
[33] for Definity (Lantheus Medical Imaging Inc., North Billerica, MA) UCAs were used to 
calculate theoretical BSCs because these were the UCAs used in all experiments. The 
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surface tension at the shell-water interface was assumed to be fixed at that of water. 
These parameters, along with some of the physical constants that were used, are 
provided in Table 2.1. Also, resonant frequency versus initial UCA radius for Definity is 
plotted for reference in Figure 2.1. 
Table 2.1 Parameters used to estimate the theoretical BSC of UCAs using the linear model 
Parameter Symbol Value Unit 
Specific heat ratio for octofluoropropane γ 1.06 - 
Density of free air at sea level Ρg0 1.29 kg/m
3 
Specific heat at constant pressure of gas Cpg 1005 J/kg 
Thermal conductivity of gas Kg 0.023 W/m/°C 
Surface tension at shell τ 0.073 N/m 
Dynamic viscosity of water ε 0.001 kg/m/s 
Shell friction Sf 0.015e-6 kg/s 
Shell parameter Sp 1.7 N/m 
 
2.3.2 Nonlinear model 
 A model for nonlinear oscillation dynamics of UCAs was developed by 
Marmottant et al. [34] and was observed to match qualitatively well with experimental 
results of radius versus time at frequencies below 10 MHz. The model is based upon a 
modified Rayleigh-Plesset equation and assumes radially symmetric oscillations; thus, 
shear viscosity terms can be neglected. Marmottant et al. introduced a novel, varying 
surface tension that is a function of the instantaneous radius of the UCA. 
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Figure 2.1 Theoretical resonance frequencies of Definity UCAs in room temperature water for 
varying resting diameters 
The varying surface tension is defined by the state of the phospholipid monolayer 
shell, which can be in three different states depending upon the instantaneous radius of 
the UCA. At some radius, Rbuckling, less than the initial radius, the shell will undergo out-
of-plane buckling, and the surface tension will be effectively zero. On the other hand, 
when the UCA rapidly expands beyond some threshold radius, Rbreak-up, the monolayer 
will likely rupture and the resulting surface tension will relax to that of the surrounding 
medium. As long as R ≥ Rruptured, the surface tension will remain at that of the 
surrounding medium. Also, Rruptured is defined as the radius that the UCA will reach 
when the surface tension returns to that of the surrounding medium, after the initial 
break-up has occurred. Usually, Rbreak-up is larger than Rruptured. In between the two 
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threshold radii, the surface tension is characterized by a linear function of the surface 
area of the UCA. The final equation of motion is given by 
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with the surface tension term 
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where R represents instantaneous radius and the dots correspond to first and second 
time derivatives, R0 is initial radius, ρ is the density of the surrounding medium, γ is the 
polytropic gas exponent, P0 is the ambient pressure of the medium, ε is the dynamic 
viscosity of the surrounding medium, κs is the surface dilatational viscosity of the shell, 
Pi is the time-dependent incident pressure, χ is the elastic compression modulus that 
can be determined experimentally, and τwater is the surface tension of the surrounding 
medium, about 73 dynes/cm. The physical properties of Definity UCAs that were used 
for the Marmottant model in this work were based upon experimental work by Goertz et 
al. [32] to determine κs and χ and are provided in Table 2.2. Note that the Sf and Sp 
parameters from the linear model are related to κs and χ by Sf = 12πκs and Sp = 2χ, 
respectively [35]. 
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Table 2.2 Parameters used in the simulations to estimate the BSC with the nonlinear model 
Parameter Symbol Value Unit 
Specific heat ratio for octofluoropropane γ 1.06 - 
Surface tension of water τwater 0.073 N/m
 
Dynamic viscosity of water ε 0.001 kg/m/s 
Surface dilatational viscosity of the shell κs 0.398e-9 kg/s 
Elastic compression modulus of the shell χ 0.855 N/m 
 
 With the estimates of UCA radius versus time that were obtained from Equation 
2.8, the far field pressure from a spherical UCA was calculated using [35] 
  22ff
R
p ρ RR R
z
 
   
 
, (2.10) 
where z is the distance between the UCA and the location of the detector. The nonlinear 
model for UCA dynamics was used to create a simulation which will be described in 
more detail in Section 3.5, and theoretical results for BSC were obtained from this 
simulation. 
 Estimation of the resonance frequency of Definity UCAs using the nonlinear 
model was accomplished by first estimating the far field pressure from a UCA excited 
with a variety of frequencies. The frequency that produced the largest scattered 
pressure was recorded as the corresponding resonant frequency for the UCA of fixed 
diameter. Note that the nonlinear model predicts a resonance frequency that is 
dependent upon PRP amplitude. In order to simulate the case of small amplitude 
oscillations using the nonlinear model, an incident PRP amplitude of 5 kPa was used to 
estimate the resonance frequencies. The results are presented in Figure 2.2. 
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Figure 2.2 Estimated resonance frequencies of Definity UCAs in room temperature water using the 
theoretical model 
 Many studies have been performed to compare the performance of the 
Marmottant model to experimental data [36], [37], [38], [39]. A recent study [37] used 
the UCA BR-14 (Bracco S.A., Geneva, Switzerland) to compare the resonant 
frequencies predicted by the Marmottant model to experimentally estimated resonances 
under 5 MHz at peak incident pressure amplitudes below 25 kPa. They obtained good 
agreement with the model and concluded that the initial concentration of shell surface 
molecules can vary among individual UCAs, even of the same size. This is important 
because the concentration of surface molecules determines the initial surface tension of 
the shell, which is directly related to its buckling radius. In [38] and [39], the Marmottant 
model was used to predict the frequency response of the backscattered power of UCAs 
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at PRP amplitudes under 150 kPa and 6 MHz. It was concluded that the model could 
accurately predict the harmonics and subharmonics at low driving pressure amplitudes.  
To date, however, the accuracy of the model has not been assessed at 
frequencies above 10 MHz. Therefore, it is a sub-aim of this work to compare the 
theoretical BSC simulated using the Marmottant model to experimental BSC estimates 
in order to evaluate the use of the model as an estimator for UCA concentration. The 
simulations use a 15-25 MHz Gaussian pulse to mimic the pulse from the transducer 
used in experiments. 
2.4 Scattering from blood 
 The scattering of ultrasound in blood has been characterized for a wide range of 
frequencies, both theoretically and experimentally [40]-[46]. Although blood has many 
components, the red blood cells (RBCs) are by far the largest component, and it is 
generally accepted that the interaction with RBCs dominates the backscattered 
response [40].  Therefore, research has been dedicated to the analysis of ultrasound 
interactions with individual RBCs, suspensions of RBCs in saline, suspensions of RBCs 
in plasma, and whole blood. Some highlights from the key findings in each of these 
areas are presented here. 
 Single RBCs are characterized by their shape, usually referred to as a biconcave 
disk, where the long axis diameter is approximately 8 µm, the short axis on the outside 
is approximately 2 µm, and the short inner axis is 1 µm, so that the total volume is about 
87 µm3 [41]. Because the solution for a biconcave disk is not closed form, many similar 
shapes with closed form solutions have been proposed to approximate that of a RBC. 
Savéry and Cloutier [42] used the solutions for a fluid sphere, flat disk, and ellipsoid to 
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compare to their estimated scattering solution for a biconcave disk. Their results for the 
backscattering cross section of these shapes are provided in Figure 2.3. The results for 
Oz are for insonification along the short axis, and Ox refers to insonification along the 
long axis. It is important to note that below approximately 28 MHz, neither the shape nor 
the insonification direction affect the backscattering cross section significantly. In this 
work, all estimation was performed below 28 MHz, and therefore, the closed form 
solution for a fluid sphere was used to model the RBC. 
  
Figure 2.3 Theoretical backscattering cross sections for fluid-filled objects of varying shapes and 
insonification directions [42], for comparison to that of a red blood cell 
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 Estimates of the experimental BSC of RBC suspensions in saline have been 
used to determine the scattering effects of blood without formation of aggregates. More 
specifically, the relationship of the hematocrit (the volume percentage of RBCs for a 
given suspension) to the BSC was examined experimentally [43]. In general, the BSC 
for a suspension of RBCs at very low concentrations is simply the backscattering cross 
section for a single RBC times the number concentration divided by the volume of the 
resolution cell; that is, the BSC is proportional to the number of RBCs. However, RBCs 
in vivo are at much higher concentrations, and these effects are usually grouped into a 
single coefficient, known as the Percus-Yevick packing factor. The closed form solution 
for packing factors of spheres has been derived, and usually this is used to compare 
experimental estimates of BSC to theoretical derivations versus hematocrit [44]. 
Because good agreement with theoretical estimations has been achieved for low 
hematocrits, these RBC-saline suspensions are often used as a reference in 
experiments estimating the BSCs of whole blood. 
 Finally, recent research in modeling the effects of whole blood aggregation on 
BSC has provided more accurate theoretical approximations when compared to 
experimental data. More specifically, a structure factor, used to describe the positions of 
the RBCs relative to each other, was developed, and so the BSC of whole blood is 
estimated by [45] 
 BSC blood bcs blood
RBC
H
SF
V
     , (2.11) 
where H is the hematrocit, VRBC is the volume of a single RBC, σbcs-blood is the 
backscattering cross section of a single RBC, approximated by a sphere for frequencies 
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under 28 MHz, and SF is the structure factor, defined as the Fourier transform of the 
pairwise correlation function g(r): 
    
22 2
0
12
1 ( ) 1
5
jkr
RBC r
H
SF g r e dr W Da k
V
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where r is the distance between two RBCs, W is the Percus-Yevick packing factor for a 
rigid sphere, D is the average aggregate diameter in number of RBCs, and a0 is the 
radius of a sphere-shaped model for a RBC, based upon VRBC. The structure factor is 
approximated using a second order Taylor series expansion to get the terms on the 
right-hand side of Equation 2.12. By fitting the experimentally estimated BSCs from 
RBC-plasma suspensions for varying hematocrits to this theoretical model for the BSC 
of blood, Yu and Cloutier [46] were able to find values for average aggregate diameter 
and packing factor for their data. In this way, their theoretical predictions better matched 
experimental BSC estimates than the models developed for RBC-saline suspensions 
which included the packing factor only. Because whole blood suspensions were used in 
the work presented in this manuscript, the model incorporating the structure factor was 
used for all in vitro experiments with blood in order to better estimate the theoretical 
BSC. Also, the closed-form solution of packing factor for flat disks was used in order to 
reduce the number of variables and approximate the shape of the RBCs.  
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CHAPTER 3 MATERIALS, METHODS, AND SIMULATIONS 
3.1 Introduction 
In the beginning of this chapter, experimental methods for estimating BSC are 
discussed briefly. Next, the glass beads and UCAs used in the four experiments are 
described. After that, a description of the methods involved for each experiment is 
included. Note that the beaker experiments were conducted initially because this was 
the simplest setup, and the flow system was developed later. Finally, the simulation 
used to estimate BSCs of UCAs using the nonlinear model introduced in Section 2.3.2 
is explained, the results of which are presented in Chapter 4. 
3.2 Experimental BSCs 
3.2.1 Planar reference technique 
 Clinical ultrasound is most often applied in the form of B-mode imaging for 
diagnostic purposes [26]. In this technique, a single scan line is obtained by sending an 
ultrasound pulse into the tissue to be imaged and collecting the backscattered 
response. A B-mode image is formed by aligning adjacent scan lines to form a two-
dimensional image. However, the values of each pixel in the image are dependent upon 
the envelope of each received scan line; thus, information about the frequency and 
phase of the response is discarded. Spectral-based quantitative ultrasound is the study 
of the frequency-dependent characteristics of the response in order to elicit tissue 
properties [47]. 
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 When a tissue is modeled as a collection of small particles randomly suspended 
in a medium, the backscattered response is treated as a linear system with a negligible 
coherent scattering component. Therefore, the backscattered response, neglecting 
frequency-dependent attenuation, is represented by 
 1
( ) ( ) ( )R f H f S f 
, (3.1) 
where H(f) is the impulse response of the transducer in pulse-echo mode and S(f) is the 
total backscattering function of the medium in the frequency domain. In order to obtain 
information about the scattering particles, it is necessary to eliminate the transducer 
transfer function H(f). One way that this is done is by placing a planar reference 
perpendicular to the propagation direction of the pulse. The scattering function of a 
planar surface is well defined by its acoustic reflection coefficient, a constant that is 
independent of frequency. Therefore, its response in the frequency domain is 
 2
( ) ( )R f H f  , (3.2) 
where Γ is the reflection coefficient of the planar reflector. The system-independent 
power spectrum is calculated by taking the ratio of the two responses 
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The experimental BSC is proportional to this power spectrum, and has been derived for 
weakly-focused transducers [24], [25]. These proportionality factors are due to the 
diffraction effects from the transducer and the length of the gated region from the 
backscattered response used to estimate the power spectrum. The equation that was 
developed to estimate experimental BSCs is 
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In this development, z0 is the distance from the transducer to the scattering volume, A0 
is the area of the transducer surface, L is the axial length of the gated signal, and Aα is 
an attenuation correction factor. 
3.2.2 Attenuation compensation 
 Because of the large impedance mismatch between the UCAs (specific acoustic 
impedance, Z0 = 880 Rayl, for octafluoropropane in Definity UCAs) and the surrounding 
medium (water at 20° C, Z0 = 1.5 MRayl), attenuation through a cloud of UCAs 
contributes heavily to the backscattered signal that is received. As a result, the signal 
power that is received by the ultrasonic transducer is reduced, which causes a reduction 
in the estimated concentration of UCAs. The attenuation is accounted for in the 
estimation of the BSC through an attenuation correction factor. Estimation of the 
attenuation correction factor has been approximated [48], and a more general correction 
factor that is valid for high number densities of evenly distributed scatterers has recently 
been derived [49]: 
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Here, α0(f), α(f) are the attenuation coefficients (Np/cm) of the intervening medium 
before the gated region and the scattering medium within the gated region, respectively, 
and x0 is the distance from the source to the gated region. 
 Because the medium was assumed to be a homogeneous mixture of UCAs and 
either degassed water or blood, the two attenuation coefficients, α0(f) and α(f), were the 
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same. They were estimated during each trial using an insertion loss technique. The 
backscattered responses from a planar reference were collected before and after the 
UCAs were added. Their ratio is used to estimate the attenuation coefficient of the UCA 
cloud as follows: 
 
 ln
4
ref
px

    . (3.6) 
In this development, αref is the (known) attenuation coefficient of the medium without 
UCAs, δ is the ratio of the frequency-dependent response without UCAs to the response 
with UCAs, and xp is the total distance that the pulse must propagate through the cloud 
of UCAs in one direction. 
3.3 Materials 
3.3.1 Glass beads 
Glass beads (Potters Industries Inc., USA) were used to validate the flow system 
experiments and the experimental estimation method of the BSC. Because the beads 
are manufactured with a distribution of sizes, it was necessary to sieve them before use 
in order to effectively compare the ESD estimates to the optically estimated diameters. 
Although it was desired to obtain glass beads with diameters comparable to UCAs (2-10 
µm), the available equipment limited the smallest size beads that could be extracted to 
approximately 50 µm. After sieving, the beads were separated by mass according to the 
desired concentration for experiments, and then they were mixed with the appropriate 
amount of degassed water. 
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 The sizes of the beads were estimated optically with a fluorescence microscope 
and camera system (Zeiss Axiovert 200M w/10x objective, Zeiss AxioCam MRm, Carl 
Zeiss Inc., Thornwood, NY) in standard bright field imaging mode. Images were 
captured with a resolution of 0.63 µm/pixel, based upon the magnification settings of the 
microscope. An example image of the glass beads under the microscope is shown in 
Figure 3.1. 
 
Figure 3.1 Bright field image of glass beads at a magnification of 10x 
 After capturing the images, a circular detection algorithm, developed by King and 
O‟Brien [50], which utilizes the Hough transform, was used to obtain glass bead 
diameter estimates. The average size distribution is shown in Figure 3.2. The average 
bead diameter was 49.5 µm with a standard deviation of 2.76 µm. 
3.3.2 UCAs 
 Definity UCAs, which have been approved for clinical use in the United States, 
were used in all of the experiments with UCAs. As reported by the manufacturer, 
Definity UCAs have a mean diameter of 1.1 – 3.3 µm, and 98% have a diameter smaller 
than 10 µm. Each vial contains 6.52 mg/mL of octafluoropropane and 0.75 mg lipid 
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blend in a sodium chloride suspension that is activated using the Vialmix sequence. 
This system agitates the Definity vial for 45 seconds for normal activation, and 
afterwards each mL of the solution is reported to contain at most 1.2x1010 
microspheres. 
 
Figure 3.2 Estimated size distribution of glass beads 
 A similar procedure used to obtain size distribution estimates for the glass beads 
was used to estimate the sizes of the UCAs. Upon capturing bright field images of a 
sample of UCAs at a magnification of 63x (0.1 µm/pixel), the circular detection algorithm 
was applied. One of these gray scale images is presented in Figure 3.3. Resulting 
histograms were divided into 0.2-µm bins because this was the estimated uncertainty in 
the measurement. It was very important to obtain accurate estimates of size 
distributions because the resonance frequency of the bubbles is highly dependent upon 
shell parameters and UCA diameter [32]. Because different vials were used for separate 
trials of the experiments, variations in UCA size distribution among vials were 
considered. However, a single histogram of UCA size for many different vials was 
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created, and the mean diameter, standard deviation, and shape of the single histogram 
were similar to the histograms of the individual vials. Therefore, the single, large size 
distribution was used as a good estimate of the UCA sizes in the experiments, and this 
distribution is presented in Figure 3.4. The mean UCA diameter was 2.2 µm and the 
standard deviation was 0.71 µm, which is within the range of sizes reported by the 
manufacturer. 
 
Figure 3.3 Bright field image of UCAs at magnification of 63x 
 Also, it is important to note that the UCAs can shrink over time. Dayton et al. [51] 
optically showed the gradual diffusion of gas from phospholipid- and albumin-shelled 
UCAs; some of the UCAs dissolved completely within minutes in their in vitro 
experiments. Droste [19] corroborated this effect in the body, reporting that the UCAs 
began to shrink within minutes of infusion. Because the BSC of UCAs depends 
significantly upon UCA size, it was necessary to consider the size distribution as a 
variable when estimating UCA concentrations from BSCs. In order to simplify 
complexity of the BSC calculation and enable faster UCA concentration estimates, a 
Gaussian size distribution was assumed for theoretical BSC calculations. 
26 
 
 
Figure 3.4 Estimated size distribution of UCAs 
 Other more complicated size distributions that more closely matched visually with 
Figure 3.4 were examined. Although these affected the shape of the theoretical BSCs at 
1-14 MHz, UCA concentration estimates were not significantly affected because 
estimates were obtained using a frequency range above 14 MHz. 
3.3.3 Experimental equipment 
 A transducer with a center frequency of 20 MHz, radius of 1/4 inch, focal distance 
of 3/4 inch (F-number of 3), and -10 dB bandwidth of 15-28 MHz was used to obtain all 
ultrasonic data. A pulser-receiver (Panametrics 5900, Waltham, MA), operating in pulse-
echo mode with a pulse repetition rate of 1 kHz and a 26 dB gain, was connected to the 
transducer. Estimation of the PRP amplitude at the transducer focus for multiple input 
energies was accomplished using a membrane hydrophone (National Physics 
Laboratory, Teddington Middlesex, UK). Because the pulse was directed through an 
acoustically transparent well plate seal in all of the experiments, the hydrophone was 
placed behind one of these seals at the focus of the transducer during PRP amplitude 
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estimation. For input energies of 1, 2, 4, 8, and 16 µJ, the corresponding estimates of 
PRP amplitude were 70, 140, 270, 390, and 510 kPa. During all of the experiments, 
these settings were used in order to study the effects of PRP amplitude on UCA 
response.  
 The linear scattering model used to estimate UCA concentrations based upon 
experimental BSCs is only valid for small oscillations, and not for the large expansions 
associated with UCA collapse. Previous studies have estimated pressure amplitudes for 
Definity above which collapse begins to occur [52], [53]. Because this threshold is 
based upon the excitation frequency, PRP amplitude, length of the pulse, and size of 
the UCAs, it is difficult to use the previous data as an indication of whether collapse is 
occurring. In the previous studies mentioned above, the frequency was below 3 MHz, 
and the pressure threshold for 5% collapse varied from 600 kPa to 1.7 MPa. Therefore, 
collapse was minimized during the experiments presented in this work by using PRP 
amplitudes below 600 kPa and an excitation frequency range far above the resonance 
frequency range.  
3.4 Methods 
3.4.1 Hemacytometer based concentration estimates 
 After ultrasonic backscatter data was captured, a sample of the UCA and 
degassed water mixture was extracted from the apparatus being used in order to obtain 
hemacytometer based UCA concentration estimates for comparison to ultrasonic based 
estimates. This was performed for two of the experiments: the beaker experiments with 
UCAs in degassed water and the flow system experiments in degassed water. The 
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sample was extracted via a 1 mL syringe and an 18 gauge hypodermic needle in order 
to minimize the loss of UCAs through the opening of the syringe.  
 For each concentration estimate, a small amount of the extracted mixture was 
inserted into the 1/25 x 1/25 x 1/10 mm3 hemacytometer (Bright-Line, Hausser 
Scientific, Buffalo, NY) chamber, which was divided into 25 laser-etched sections of 
equal volume. The number of UCAs in ten of the 25 sections was recorded, and the 
resulting concentration was converted to the number of UCAs per mL. Because the 
UCAs were much smaller than the hemacytometer chamber, they could easily move 
around while being counted. Often, the UCAs were not evenly distributed, and they 
moved due to their buoyancy and small currents in the chamber. For this reason, the 
hemacytometer based estimates were repeated six times for each experimental trial in 
order to estimate the average concentration of UCAs in the extracted mixture.  
3.4.2 Beaker experiments 
 Initially, backscatter measurements were acquired with a beaker apparatus, 
modified to allow for the insertion and extraction of UCAs without moving any system 
components. A diagram and photograph of the chamber is shown in Figure 3.5. The 
chamber was first sealed with waterproof epoxy, and then two holes were drilled into the 
top. The first hole was sealed with an acoustically transparent well plate seal (Thermo-
Scientific ABgene Adhesive Plate Seals, AB-0580, Hudson, NH) and the second was 
used for the insertion and extraction of degassed water and Definity UCAs. Backscatter 
data was acquired from the vertically mounted 20-MHz transducer, positioned above the 
seal so that the ultrasonic pulse was directed downward and normal to the seal. Within 
two centimeters below the seal, a flat Plexiglas reflector was fixed to allow for new 
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reference measurements to be taken with each trial. Because the reference 
measurements were acquired through the well plate seal, the transmission effects from 
the seal were included in the reference. A stir bar inside the apparatus was used to 
ensure an even distribution of microbubbles at the measuring site, and the entire 
chamber was placed in a tank filled with degassed water. 
 
Figure 3.5 Experimental setup for the beaker system 
 After both reference measurements and noise floor estimates were recorded, the 
UCAs were inserted into degassed water with concentrations of 1x and 2x the dosage 
recommended by the manufacturer for diagnostic imaging, equal to 8x10-5 mL of 
Definity solution per mL. For each trial, 500 snapshots of the backscatter from the UCAs 
were acquired at three separate depths in the chamber. This was performed so that the 
distance between estimates was 4 mm. The transducer was then moved to place the 
focus back on the Plexiglas reflector so that reference measurements with the UCAs 
could be acquired. These were then used to estimate attenuation for each trial. Before 
the experimental BSC was calculated, the noise spectrum was subtracted. Also, the 
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axial length of the scattering volume used to calculate the normalized spectrum was 
equal to 15 times the wavelength of the 20-MHz pulse.  
3.4.3 Flow system experiments 
3.4.3.1 Description of the flow system and experimental procedure 
 The flow system was developed to emulate dynamic conditions like blood flow in 
the body. Powered by a peristaltic pump (Masterflex Variable Speed Economy Console 
Drive, Vernon Hills, IL), the system drew the UCA or glass bead mixture from a beaker 
to a specially designed Plexiglas® chamber. The chamber was built to increase the 
cross-sectional area of the flow from that of the tubing while minimizing sidewall effects 
and turbulence development near the measurement site. A diagram of the flow system 
and a photograph of the chamber are shown in Figure 3.6. After the mixture was drawn 
through the 3/8 inch opening at the bottom of the chamber, it rose vertically through the 
diverging opening, passing the measurement site when the cross section of the flow 
was 3/2 x 3/8 square inches. Two holes were drilled horizontally into the chamber: the 
lower hole was drilled at the measurement site, where one of the acoustically 
transparent well plate seals prevented the UCA mixture from escaping, and the upper 
hole contained a rubber stopper, from which a sample of the mixture could be extracted 
after the backscatter data was acquired. The 20-MHz transducer was positioned so that 
the ultrasound pulse was directed horizontally through the well plate seal and focused 
inside the chamber or at the back plane wall for reference measurements. After passing 
the second hole, the flow diverged again through the top 3/8 inch opening. Finally, the 
flow passed through the pump and was discarded into the original beaker, where a 
large stir bar kept the mixture from separating. 
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Figure 3.6 Diagram of the flow system indicating location of the flow chamber, transducer, and 
pump, and corresponding photograph of the chamber 
 In order to estimate the BSC, estimates of the pulse-echo impulse response of 
the transducer were approximated by capturing the reflections from the pulse focused at 
the back plane wall of the Plexiglas chamber when only degassed water flowed through 
the system. These reference measurements were used to eliminate the system 
dependent characteristics, as detailed in Section 3.2.1. An estimate of the noise floor 
spectrum was also obtained by focusing the pulse inside the chamber filled with water. 
After inserting UCAs or glass beads, 500 or 1000 snapshots of the backscattered 
ultrasound from the mixture were procured. Reference measurements of the back plane 
wall were repeated in order to estimate attenuation for each trial. The backscattered 
snapshots were gated around the location of the focus, such that the length of the gate 
was equal to 15 times the wavelength of the 20-MHz pulse. Before calculating the 
normalized power spectrum, the noise spectrum was subtracted.  
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3.4.3.2 Experiments with glass beads in degassed water 
 Initial experiments with the flow system were conducted with glass beads in 
degassed water. Concentrations of 5 g and 10 g of beads in 500 mL of degassed water 
were inserted into the beaker before backscatter estimates were obtained. Because the 
upward flow inside the chamber worked against the natural tendency of the beads to 
settle downward, the flow rate was adjusted to 1320 mL/min during all trials. Also, the 
speed of the stir bar in the beaker was increased to prevent settling inside the beaker. 
This speed was adjusted until the cloud of beads was visibly distributed throughout the 
beaker.  
 Because the average diameter of the beads was estimated with a microscope to 
be 49.5 µm, the concentrations used in each trial were too low to use the 
hemacytometer for verification. This is because as the diameter of an object increases, 
fewer of those objects are required to obtain the same concentration value. Because the 
concentration of glass beads inside the chamber might not have been the same as the 
concentration of beads inserted into the beaker, a more accurate technique for verifying 
the concentration inside the chamber was developed. After measurements of the 
backscatter from the beads were acquired, 100 mL of the bead and degassed water 
mixture that exited the chamber was collected. The mixture was then heated to 
separate the glass beads from the water, and the final mass of beads was used to 
determine the overall concentration. 
3.4.3.3 Experiments with UCAs in degassed water 
 After experiments with glass beads in degassed water were conducted, trials with 
UCAs in degassed water were performed. For these experiments, concentrations of 1x, 
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2x, and 5x the concentration recommended by the manufacturer for imaging (8x10-5 mL 
of Definity solution per mL) were used. The physical properties of the UCAs are different 
from the glass spheres, and so procedures were adjusted as follows. Because the 
UCAs flowed vertically upward, they moved in the direction of the natural buoyant force 
that acted upon them. Also, UCAs are easily destroyed when subject to stresses such 
as high flow rates, overly rigorous mixing, and the mechanical motion of the pump, 
which will reduce the number of UCAs in the system. Therefore, the flow rate was 
reduced to approximately 350 mL/min.  
 In order to estimate the available timeframe for acquiring estimates before the 
loss of UCAs in the system significantly reduced the ultrasonically estimated UCA 
concentration, an additional trial was performed. After insertion of a 1x concentration of 
UCAs, 1000 snapshots of the backscatter were acquired every 5 minutes over a period 
of 15 minutes. After 10 minutes, the estimated concentration of UCAs was reduced by 
approximately 2%, and after 15 minutes, the estimated concentration had decreased by 
just less than 5%. All of the ultrasonic data from the regular trials was acquired within 7 
minutes after the UCAs had been inserted into the beaker, and so the estimates of 
concentration were minimally affected by the rate of UCA loss in the system. 
3.4.3.4 Experiments with UCAs in blood 
 The final experimental trials were performed with UCAs in porcine whole blood. 
Immediately after fresh porcine blood was collected, 3 g/L of ethylene diamine tetra 
acetic acid (EDTA) was added and thoroughly mixed to prevent coagulation. The 
amount of anticoagulant used was based upon the concentration of EDTA used in 
previous studies with whole blood [46], [54]. Care was taken to ensure that the blood 
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was constantly mixed, and all experiments were performed within six hours of the blood 
acquisition in order to ensure freshness. 
 The BSC of blood was used as a reference in order to estimate the BSC of UCAs 
in blood. The reason for this choice is because, in order to account for all system 
dependencies and attenuation at the site of interrogation in vivo, a reference at that site 
is required. The ratio of the backscattered power from blood with UCAs to blood alone 
can be represented as follows, assuming that the scattering from blood and UCAs 
together is the sum in the time domain of the scattering from blood and UCAs alone: 
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where |RUCA+b(f)|
2 is the backscattered power spectrum from the UCAs in blood, |Rb(f)|
2 
is the backscattered power spectrum from the blood alone, SUCA and Sb are the 
magnitudes of the backscattered response in the frequency domain, and the * 
corresponds to the complex conjugate of the response. If the ratio of SUCA to Sb is much 
greater than one, then only the squared term on the right-hand side dominates. 
Therefore, the power spectrum of the UCAs, |SUCA(f)|
2, can be estimated if |Sb(f)|
2 is 
known.  
 Using the development from Chapter 2.4 for calculating σBSC-blood, the estimated 
BSC of UCAs in blood is 
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where σBSC-blood is the BSC of blood alone. Therefore, in order to estimate the BSC of 
UCAs in blood, it is necessary to acquire the backscattered response from the blood 
35 
 
alone. The BSC of blood alone was estimated for comparison to theoretical calculations 
of blood BSC. To do this, the same procedure, as outlined in Section 3.4.3.1 and 
including the subtraction of the noise floor and the same length of the gated window, 
was used to estimate the normalized power spectrum. First, reference measurements of 
the back planar wall of the flow system chamber were acquired with only degassed 
water in the system. Next, the focus of the transducer was positioned inside the 
chamber to obtain an estimate of the noise floor spectrum. After insertion of the blood 
into the system, 500 or 1000 snapshots of the backscatter were used to obtain 
estimates of blood BSC, and the reference measurements were repeated with the blood 
inserted to estimate the attenuation through blood for each trial. 
 After estimates of the backscattered power from blood were acquired, the UCAs 
were inserted into the beaker at a concentration of 2x the dosage recommended by the 
manufacturer. Backscatter data was captured for the UCAs in blood, as well as a 
reference measurement for attenuation estimation. 
3.4.4 UCA concentration estimation 
 Ultrasonic based UCA concentration estimates were obtained by fitting the 
experimental BSC to the linear theoretical scattering model reviewed in Section 2.3.1To 
perform the fitting, a Levenberg-Marquardt algorithm [55], [56] was implemented in 
Matlab (MathWorks, Natick, MA). This recursive method for nonlinear least squares 
minimization combines the method of gradient descent with Gauss-Newton iteration and 
was implemented using three variables. Assuming fixed shell parameter Sp, shell friction 
Sf, and surface tension τ, with values provided in Table 2.1, the UCA size distribution 
parameters and the UCA concentration define the theoretical linear BSC of UCAs for a 
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fixed frequency range. As explained in Section 3.3.2, a Gaussian size distribution was 
used to simplify computation; therefore, the two other variables in the estimation 
technique were the size distribution parameters: mean diameter and standard deviation 
in diameter of the UCAs. The procedure for fitting each experimental BSC to a 
theoretical one was as follows: first, initial guesses for the three variables were used to 
calculate a theoretical BSC. Next, the root mean square error (RMSE) was calculated 
between the theoretical and experimental BSCs. Using the Levenberg-Marquardt 
formulation, a new theoretical BSC was derived, the RMSE was recalculated, and it was 
compared to the previous RMSE value. The algorithm was programmed to stop when 
10,000 iterations were reached or the RMSE did not improve by more than 0.1% from 
the previous iteration. The outputs of the algorithm included the final estimated 
concentration of UCAs, mean UCA diameter and standard deviation, number of 
iterations, and total time required for convergence. Matrix operations were used in the 
Levenberg-Marquardt formulation, and so if one of these matrices became singular 
during the iterative process, the algorithm would return an error. In this case, the 
algorithm did not converge to an estimate of UCA concentration. 
 Because initial guesses for the three variables were required to begin the 
estimation sequence, the final concentration estimate may have been sensitive to these 
guesses. However, the regions of convergence for the algorithm were not rigorously 
determined in this work. Instead, a more simplified procedure was used to examine the 
effects of initial guesses on the UCA concentration estimate, and this procedure is 
outlined here. For each trial, regardless of the concentration of UCAs that was inserted 
into the beaker, the initial guess for UCA concentration was first set to 9.6x105 
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UCAs/mL, which corresponds to the 1x dosage recommended by the manufacturer. The 
initial size distribution parameters were fixed at 2.2 µm for the mean diameter and 0.71 
µm for the standard deviation because these were the parameters from the optical 
estimate of UCA size distribution. Next, the initial UCA concentration was varied to find 
a range of initial guesses for concentration that led to convergence of the algorithm. It 
was found that for all trials, the algorithm converged only for initial concentrations within 
100 times the final estimate, and that it converged to the same concentration estimate 
for all initial values of concentration within that range. This was the final concentration 
estimate that was reported in the results. 
 The limits for initial guesses of the size distribution parameters were also 
interrogated. The initial UCA concentration value was fixed to within 100 times the final 
concentration estimate, and the initial values for mean diameter and standard deviation 
were varied. The limits of the initial values were 1 to 8 µm and 0.4 to 3 µm for the mean 
diameter and standard deviation, respectively. These limits were based upon the limits 
of the UCA size distribution estimates and the size limits reported by the UCA 
manufacturer. When the initial size distribution parameters were varied within these 
limits, the resulting UCA concentration estimates differed by less than 2% for all trials. 
Therefore, it was concluded that the initial values of the size distribution parameters 
were not a limiting factor for the UCA concentration estimates reported in this work. 
3.5 Simulations of the BSC 
 A simulation was developed in Matlab to estimate the BSC based upon the 
nonlinear model for UCA dynamics presented in Section 2.3.2. The model is used to 
estimate the oscillatory behavior of UCAs exposed to an ultrasound pulse, which 
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produces a pressure wave that propagates back to the insonifying transducer. The 
pressure waves from each UCA in the insonified volume are summed at the insonifying 
transducer surface to simulate the received response. An overview of the simulation is 
presented here.  
  The simulation requires inputs of size distribution parameters and the PRP 
amplitude of the insonifying pulse. First, the scattering volume was defined as a 
rectangular prism, where two sides had equal lengths of twice the wavelength of a 20 
MHz transducer times the F-number, and the third side had a length of 15 times the 20 
MHz wavelength. The total volume was 0.60 mm3. The volume was discretized both 
uniformly and so that the minimum distance between any two points in the volume was 
10 µm. Based upon the input value for the concentration of UCAs and the total volume, 
the number of UCAs inside the scattering volume was determined.  
 In order to simulate the average response rather than an individual one, the 
simulation was repeated 500 times for each BSC estimate. For each of the responses, 
new locations for all of the UCAs inside the scattering volume were randomly assigned. 
Each UCA in the volume was also assigned a resting diameter based upon the input 
size distribution parameters. Next, a 20-MHz center frequency Gaussian pulse with a 
fractional bandwidth of 80% was generated to imitate the impulse response of the 
transducer used in the experiments. Field II [57], [58], a program developed to simulate 
the spatial impulse response of a transducer with finite dimensions as a sum of discrete 
point sources, was used to estimate the spatial impulse response for a concave circular 
transducer with the same dimensions and focal length as the 20 MHz transducer used 
in the experiments. The time-varying pressure at the location of each UCA in the field of 
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the transducer was calculated as the convolution of the spatial impulse response with 
the generated Gaussian impulse response of the transducer [57]. After the input 
pressure for each UCA was normalized to the desired PRP amplitude, the equation of 
motion presented in Equation 2.8 was used to estimate radius versus time curves based 
upon each calculated input pressure. 
 Assuming that each UCA acted as a spherical source, the far field pressure wave 
front was spherically shaped. In the simulation, the ultrasonic response obtained by the 
transducer was assumed to be due to UCA oscillations and not due to scattered 
reflections of the pulse. This assumption was based upon a previous study [59] that 
reported that the error due to neglecting the passive part of scattering from UCAs was 
less than 0.25% for 0 3 / 2R λ π , where λ is the wavelength of the applied ultrasound. 
At 28 MHz, approximately the smallest wavelength used to excite the UCAs in the 
simulation, this limiting radius is about 15 µm, which is much larger than the radii of 
Definity UCAs. Neglecting any multiple scattering effects, the simulated response 
obtained by the transducer was estimated as the sum of the scattered pressures from 
each UCA, shifted in time according to their distances from the transducer surface. This 
time shift was calculated by convolving the scattered pressures with their corresponding 
spatial impulse responses and the Gaussian impulse response of the transducer. 
 After the simulation acquired 500 responses for each set of randomly distributed 
UCAs, the simulated reference response was generated using the reflection coefficient 
of a Plexiglas plate. Finally, Equation 3.4 was utilized to estimate the BSC using the 
nonlinear model. The results for the estimated BSCs of UCAs from this simulation were 
then compared with experimental BSC estimates and theoretical calculations with the 
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linear model. Figure 3.7 presents a diagram of the simulation with the major steps 
highlighted. 
 
Figure 3.7 Overview of the simulation steps used to estimate the BSC of UCAs with the nonlinear 
model for UCA dynamics  
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CHAPTER 4 RESULTS 
4.1 Theoretical BSCs of UCAs 
 The linear model was used to estimate the BSC for varying parameters of the 
Gaussian UCA size distribution in order to determine an optimal frequency range for 
extracting UCA concentration estimates. Over the optimal range of frequencies, 
changes in the size distribution would have a minimal effect on the BSC, and therefore 
the concentration of UCAs would dominate. Using Equation 2.4, the scattering cross 
sections for single UCAs of varying radii were calculated. These were used to determine 
the relative contributions of UCA size, and whether the differences in the radii of a 
polydisperse scattering volume of UCAs would significantly affect the shape of the BSC. 
Figure 4.1 shows the scattering cross sections of UCAs with radii from 0.25 to 5 µm 
based upon the linear model. 
 
Figure 4.1 Scattering cross sections for single UCAs of various diameters, calculated using the 
linear model 
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 Because the scattering cross sections of the larger UCAs dominated the 
contributions to the BSC and the estimated UCA size distribution contained a large 
number of UCAs with 0.4-1.5 µm radii, the contributions of the smaller UCAs with 
resonant frequencies close to 20 MHz were insignificant compared to the larger UCAs 
with resonant frequencies near 4-12 MHz. It was therefore determined that the optimal 
frequency range for extracting UCA concentration estimates was above 4-12 MHz. 
Above 12 MHz, the resonant frequencies of the UCAs could be avoided where 
nonlinear oscillations were more likely to occur. Although different UCA scattering 
models usually predict slightly different resonance frequencies, knowledge of the exact 
resonant frequency was not necessary when estimates were extracted from scattering 
behavior above 14 MHz. 
 The collective effects of a polydisperse scattering volume on the theoretical BSC 
were also examined. This was achieved by holding one of the size distribution 
parameters constant while varying the other. For a Gaussian size distribution with 
parameters of mean UCA diameter and standard deviation in diameter, this technique 
was used to calculate the theoretical BSC. In Figure 4.2, the mean UCA diameter was 
fixed at 2.2 µm and the standard deviation was varied from 0.3 to 1.5 µm. Figure 4.3 
shows the BSC when the standard deviation was held constant at 0.71 µm and the 
mean UCA diameter was varied from 0.8 to 3.6 µm. The fixed parameters were 
obtained by fitting a Gaussian distribution to the optical size distribution estimate of the 
UCAs for all vials of Definity combined. The estimated size distribution in each individual 
vial was also fit to a Gaussian distribution. The ranges of size distribution parameters 
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that were examined were based upon the results from fitting the Gaussian distribution to 
the individual vials. 
 
Figure 4.2 Theoretical BSC of UCAs calculated using the linear model, a Gaussian size 
distribution, and the following parameters: a constant mean UCA diameter of 2.2 µm and varying 
standard deviations in diameter 
 For the mean diameters less than 2.2 µm in Figure 4.3, the resonant peak was 
not nearly as steep. This can be explained based upon the results and short discussion 
of Figure 4.1. Although the smaller UCAs had resonant frequencies that should have 
shifted the peak toward higher frequencies, the contributions from the larger UCAs 
dominated, and the result was a broadening of the resonant peak. In order to determine 
the frequencies at which the changes in Gaussian size distribution parameters would 
have the least effect on the theoretical BSC of UCAs, the curves in Figure 4.2 and 
Figure 4.3 were compared as follows: the curve with the largest magnitude BSC was 
subtracted from the curve with the lowest magnitude, and the frequency at which this 
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difference was minimized corresponded to the least change in BSC due to changes in 
size distribution.  
 
Figure 4.3 Theoretical BSC of UCAs calculated using the linear model, a Gaussian size 
distribution, and the following parameters: a constant standard deviation in UCA diameter of 0.71 
µm and varying mean diameters 
 In Figure 4.2 this minimum difference occurred at 14 MHz, and the change in 
BSC remained approximately constant from 14 to 50 MHz. In Figure 4.3, the minimum 
difference between BSCs also occurred at 14 MHz, but the difference increased again 
from 14 to 50 MHz. From 14 to 30 MHz, the differences were smallest for both figures 
and the changes in mean diameter changed the slope of the BSC curve but did not 
affect its magnitude significantly. On the other hand, the greatest difference between 
BSCs in both figures occurred below 12 MHz because this was where the resonance of 
the larger UCAs dominated the scattered power. 
 Based upon this analysis, a 20 MHz transducer was chosen for the experiments 
because the corresponding -10 dB bandwidth was 15-28 MHz. Using this range to 
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extract estimates of UCA concentration ensured that the changes in standard deviation 
of UCA diameters would have a minimal effect on the BSC and that the changes in 
mean diameter would affect the BSC in a predictable way. This allowed the Levenberg-
Marquardt regression to converge to a more robust UCA concentration estimate using 
less iteration. Because the experimental BSC was found to deviate from the linear 
model‟s predictions above 25 MHz, the frequency range used to extract concentration 
estimates was modified to 15-25 MHz, and this was the range used for all the UCA 
concentration estimates reported in this work. 
4.2 Theoretical BSCs of blood 
 The parameters from the theoretical BSC of blood, calculated using Equation 
2.11, were also varied to determine the effects of aggregate diameter and hematocrit on 
the theoretical BSC of blood. The hematocrit was varied from 30% to 55% to reflect the 
hematocrits of whole blood. Aggregate diameter, on the other hand, was varied from 0.2 
to 1.0 RBCs per aggregate. Although an aggregate diameter of less than 1.0 RBCs 
does not correspond to a physical aggregate of RBCs, the previous experimental 
estimates of blood BSC have been fit to the theoretical approximation, and an 
aggregate diameter approximation of less than 1.0 RBCs was common for whole blood 
[46]. To examine the effects of each parameter on the calculation of the blood BSC, a 
technique similar to that described in Section 4.1 was used. First, the aggregate 
diameter was held constant at 0.5 RBCs, and the hematocrit was varied from 30% to 
55%. The resulting BSCs are shown in Figure 4.4. 
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Figure 4.4 Theoretical BSC of blood for fixed aggregate diameter (D) in number of RBCs and 
varying hematocrit (H), which is reported as the volume fraction of RBCs in whole blood 
 As the hematocrit increased, the slope of the BSC decreased. Also, because the 
structure factor (SF) in Equation 2.12 was approximated to second order, its accuracy 
was limited to lower frequencies. The SF was approximated as the difference between 
the packing factor (the low frequency limit of the SF) and a frequency-dependent term 
that incorporated the aggregate diameter.  When the packing factor was less than the 
aggregate diameter term, the approximation resulted in a negative BSC, which is not 
physically possible. Therefore, the limit of the SF approximation was based upon the 
frequency at which the BSC dropped rapidly and became negative. This frequency was 
called the cutoff frequency in this work. In Figure 4.4 the cutoff frequency decreased as 
hematocrit increased because the packing factor of flat disks was dependent upon the 
hematocrit. 
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 Changes in BSC due to a varying aggregate diameter were also investigated. In 
Figure 4.5 the theoretical BSC of blood was calculated for a fixed hematocrit of 40% 
and an aggregate diameter that varied from 0.2-1.0 RBCs. As aggregate diameter 
increased, the slope of the BSC decreased. Also, the cutoff frequency was significantly 
reduced to approximately 23 MHz for an aggregate diameter of 1.0 RBCs. This was 
because the aggregate diameter term directly affected the SF approximation. Because 
the frequency range used in the experiments with blood was 15-25 MHz, the 
approximation for the SF had a large effect on the theoretical BSC of blood used as a 
reference to estimate the BSC of UCAs. For this reason, and to simplify the calculation, 
the aggregate diameter was set to zero for the initial experiments with UCAs in blood. 
 
Figure 4.5 Theoretical BSC of blood for fixed hematocrit (H), which is reported as the volume 
fraction of RBCs in whole blood, and varying aggregate diameter (D) in number of RBCs 
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4.3 Experimental results from the beaker experiments 
 Results for the beaker experiments were collected for multiple trials and 
iterations to improve the estimation of the BSC and the hemacytometer based UCA 
concentration estimates. The estimated attenuation and BSCs from three different 
depths in the beaker, separated by 4 mm, are shown in Figure 4.6 and Figure 4.7 for 
the final trial. The peak of the attenuation coefficient is near 16 MHz and then it 
decreases to less than 5 dB/cm at about 25 MHz. Ultrasonic data was acquired after a 
1x concentration of UCAs had been inserted and allowed to mix for one minute. The 
incident PRP amplitude used to obtain the BSCs in Figure 4.7 was 140 kPa. 
 
Figure 4.6 Attenuation coefficient of UCAs in the beaker experiments, where the UCAs were 
inserted at 1x concentration, and for a PRP amplitude of 140 kPa 
 UCA concentration estimates were obtained for the three estimates of BSC 
corresponding to locations inside the beaker. Hemacytometer based estimates were 
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the BSC was estimated. Because this was difficult to visually estimate, only two 
locations (top and bottom) were acquired. The results of the hemacytometer based 
estimates of UCA concentration, the corresponding ultrasonic based estimates, and the 
total time for the Levenberg-Marquardt regression to converge are reported in Table 
4.1. 
 
Figure 4.7 Estimated BSC of UCAs inserted at 1x concentration for various heights (top, middle, 
bottom) inside the beaker, each separated by 4 mm, and for an incident PRP amplitude of 140 kPa 
Table 4.1 UCA concentration estimates at various heights inside the beaker, where each location 
is separated by 4 mm 
Position in Beaker top middle bottom 
Hemacytometer Based 
Concentration 
(UCAs/mL) 3.8 ± 0.8E+06 N/A 3.0 ± 0.7E+05 
Estimated 
Concentration 
(UCAs/mL) 4.9E+06 1.5E+06 8.5E+05 
Elapsed Time  
to Converge (s) 0.26 0.13 0.14 
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Figure 4.8 Estimated BSC and corresponding Faran theory for 5 g of glass beads in 500 mL of 
degassed water 
4.4 Experimental results from the flow system 
4.4.1 Glass beads in degassed water 
 The resulting BSCs and corresponding Faran theory for one trial of the two 
concentrations used with the glass beads is presented in Figure 4.8 and Figure 4.9. The 
frequencies presented in the figures were used for ESD and ESC analysis and were 
based upon the -10 dB bandwidth of the 20-MHz transducer. The estimates of these 
parameters are presented for the trials shown in the figures as well as for another trial in 
Table 4.2. The reported concentration was determined by heating the glass bead and 
UCA mixture and estimating the final mass of beads, as explained in Section 3.4.3.2 For 
both trials, ESD estimates were no more than 1.6% different from the optically 
estimated mean size of 49.5 µm. Also, for the first trial, the ESC was within 3.4% of the 
lower bead concentration estimate, acquired using the water evaporation technique, 
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and within 2.4% of the higher concentration estimate. For the second trial, the lower 
concentration estimate differed from the ESC by 6.4% and the higher concentration 
differed by 2.8%. 
 
Figure 4.9 Estimated BSC and corresponding Faran theory for 10 g of glass beads in 500 mL of 
degassed water 
Table 4.2 Estimated glass bead concentrations and diameters, using a water evaporation 
technique and an ultrasonic, BSC-based technique 
Trial 1 
ESD (µm) 49.5 49.5 
ESC (beads/mL) 4.8E+04 1.00E+05 
Estimated 
Concentration 
(beads/mL) 5.0E+04 9.9E+04 
Trial 2 
ESD (µm) 48.7 48.8 
ESC (beads/mL) 4.7E+04 1.03E+05 
Estimated 
Concentration 
(beads/mL) 4.4E+04 1.06E+05 
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4.4.2 UCAs in degassed water 
 Attenuation estimates were acquired for each trial with the UCAs in degassed 
water in order to more accurately compensate for attenuation in the system. Because 
the trials were performed for varying incident PRP amplitudes, the corresponding 
attenuation coefficient was used to estimate the BSCs. The estimated attenuation for 
varying PRP amplitude is shown in Figure 4.10 for one trial of each of the 1x, 2x and 5x 
concentrations used in the experiments. For all trials, the attenuation coefficient peaked 
somewhere below 15 MHz and decreased with increasing frequency. For lower 
frequencies, the attenuation increased with increasing PRP amplitude; however, above 
approximately 20 MHz, the attenuation was not significantly dependent upon PRP 
amplitude. This indicated that the incident PRP amplitude was important for estimating 
attenuation for excitation frequencies close to the resonant frequencies of the majority 
of the UCAs, but the PRP amplitude was less important for higher excitation 
frequencies. 
 The BSC results for varying incident PRP amplitude and a single trial for each of 
the concentrations is shown in Figure 4.11. The BSCs correlate well with the predictions 
of the linear model, as in Figure 4.2 and Figure 4.3. That is, for a poly-disperse volume 
of randomly distributed UCAs with estimated mean diameter of 2.2 µm, the BSC 
decreases and then stays relatively constant for increasing frequency. Also, for 
increasing PRP amplitude the BSCs are not the same as predicted by the linear model. 
This indicates that nonlinear UCA behavior is present even for incident PRP amplitudes 
as low as 390 kPa. The corresponding UCA concentration estimates decreased with 
increasing PRP amplitudes as is evident in the estimated BSCs (Figure 4.11). 
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(a) 
 
(b) 
 
(c) 
 
Figure 4.10 Attenuation coefficient of UCAs in degassed water versus frequency for varying 
incident PRP amplitudes (in kPa) and UCA concentrations of (a) 1x, (b) 2x, and (c) 5x dosage 
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(a) 
 
(b) 
 
(c) 
Figure 4.11 Experimental BSC estimates of UCAs in degassed water for varying incident PRP 
amplitudes and concentrations of (a) 1x, (b) 2x, and (c) 5x dosage 
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 Estimates of UCA concentration were obtained for at least four trials for each of 
the 1x, 2x, and 5x concentrations used in the experiments with UCAs in degassed 
water. These estimates are given in Table 4.3 and were acquired from the experimental 
BSCs using the Levenberg-Marquardt regression algorithm outlined in Section 3.4.4  
Table 4.3 UCA concentration estimates in degassed water acquired with the hemacytometer and 
using the Levenberg-Marquardt regression from BSCs obtained using a PRP amplitude of 140 kPa 
1x Concentration 
Hemacytometer 
Based  
Concentration 
(UCAs/mL) 
2.1 ± 0.7E+06 1.8 ± 0.4E+06  1.7 ± 0.4E+06 1.1 ± 3.4E+06 
Estimated 
Concentration 
(UCAs/mL) 
2.5E+06 2.1E+06 2.1E+06 1.1E+06 
Elapsed Time to 
Converge (s) 
 0.35 0.41 0.44 0.31 
2x Concentration 
Hemacytometer 
Based 
Concentration 
(UCAs/mL) 
4.6 ± 0.5E+06 4.3 ± 1.3E+06  3.3 ± 0.7E+06 3.3 ± 1.0E+06 
Estimated 
Concentration 
(UCAs/mL) 
4.7E+06 3.7E+06 3.6E+06 3.2E+06 
Elapsed Time to 
Converge (s) 
0.32 0.12 0.55 0.51 
5x Concentration 
Hemacytometer 
Based 
Concentration 
(UCAs/mL) 
8.2 ± 1.3E+06 7.1 ± 1.1E+06 6.7 ± 1.6E+06 1.0 ± 0.4E+07  
Estimated 
Concentration 
(UCAs/mL) 
8.4E+06 6.1E+06 7.4E+06 1.2E+07 
Elapsed Time to 
Converge (s) 
0.42 0.35 0.42 0.61 
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 The hemacytometer based estimates were included for comparison and to 
determine the accuracy of the ultrasonic based UCA concentration estimation 
technique. They are reported with the average and standard deviation of the six 
hemacytometer based concentration estimates that were acquired for each trial. All of 
the ultrasonic based estimates in this table were obtained using the backscatter from 
UCAs excited with a PRP amplitude of 140 kPa because this was the PRP that gave the 
optimal estimates compared to the hemacytometer based estimates. The UCA 
concentration estimates reported in Table 4.3 were all within one standard deviation of 
the hemacytometer based estimates. In order to determine the effects of PRP amplitude 
on the UCA concentration estimates, estimates were acquired from BSCs obtained 
using various PRP amplitudes. For simplicity, only a single trial from each of the 1x, 2x, 
and 5x concentrations is reported in Table 4.4 for varying PRP amplitude. Although the 
ultrasonic based estimates of UCA concentration differed for varying PRP amplitudes, 
they were still within one standard deviation of the hemacytometer based estimates 
when using PRPs between 140-390 kPa. 
4.4.3 UCAs in blood 
 Estimates of the attenuation coefficient through blood and the BSC of blood were 
acquired for comparison to previous work and to the theoretical calculations. Because 
blood has pulsatile value in vivo, it was valuable to compare the estimates of 
attenuation coefficient based upon the flow system data to previous studies performed 
for varying shear rates. Franceschini et al. [54] estimated whole blood attenuation at 
40% hematocrit for shear rates of 5-50 s-1. Their results are shown in Table 4.5. 
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Table 4.4 UCA concentration estimates in degassed water acquired with the hemacytometer and 
using the Levenberg-Marquardt regression from BSCs obtained using varying PRP amplitudes 
1x Concentration 
Hemacytometer Based 
Concentration (UCAs/mL) 
2.1 ± 0.7E+06  
PRP (kPa) 70 140 390 
Estimated 
2.8E+06 2.5E+06 1.5E+06 Concentration 
(UCAs/mL) 
  
  
  
2x Concentration 
Hemacytometer Based 
Concentration (UCAs/mL) 
4.6 ± 0.5E+06  
PRP (kPa) 70 140 390 
Estimated 
5.2E+06 4.7E+06 4.3E+06 Concentration 
(UCAs/mL) 
  
  
  
5x Concentration 
Hemacytometer Based 
Concentration (UCAs/mL) 
8.2 ± 1.3E+06  
PRP (kPa) 70 140 390 
Estimated 
8.1E+06 8.4E+06 7.0E+06 Concentration 
(UCAs/mL) 
 
Table 4.5 Estimated attenuation coefficient of porcine whole blood at 40% hematocrit for varying 
shear rates [54] 
Shear Rate (s-1) 5 10 20 30 50 
Attenuation  
Coefficent (dB/cm/MHz) 
0.053 ± 
0.011 
0.036 ± 
0.008 
0.024 ± 
0.005 
0.016 ± 
0.003 
0.015 ± 
0.003 
 
 The estimated attenuation coefficients obtained from the flow system 
experiments are shown in Figure 4.12. The attenuation was again estimated for varying 
PRP, and based upon a flow rate of 350 mL/min. The figure also contains the 
attenuation for the four lowest shear rates reported in Table 4.5 because their slopes 
more closely matched the experimental data. 
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Figure 4.12 Estimated attenuation coefficient of blood using the flow system for varying PRP 
amplitudes, and previous estimated attenuation [54] for varying shear rates 
 The slope of the attenuation estimate through blood acquired with an incident 
PRP amplitude of 270 kPa was slightly lower than the estimates acquired with incident 
PRP amplitudes of 390 kPa and 510 kPa. Also, the attenuation slope estimate obtained 
with higher PRP amplitudes and the flow system was similar to the attenuation slope 
reported in the literature for a shear rate of 5 s-1. However, the magnitude of the 
attenuation coefficient was different. 
 The experimental estimates of attenuation through blood were used to estimate 
the BSC of the blood. Based upon the calculation of theoretical BSCs of blood, the 
results from these initial experiments were compared to theoretical BSCs without 
aggregation (the aggregate diameter was set to zero in Equation 2.12). During the 
experiments, the signal-to-noise ratio (SNR) was noticeably low, even for the highest 
PRP amplitude of 510 kPa. As a result, when the noise spectrum was subtracted from 
the mean backscattered power spectrum of the blood, the resulting signal was close to 
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zero and even negative in some places. Figure 4.13 shows the results of the BSC 
estimate of blood for varying PRP amplitude, with the negative values missing. The 
figure also contains the theoretical BSC of blood based upon Equation 2.11 for three 
hematocrits. Note that if the aggregate diameter in the equation were increased above 
zero, the slope of the resulting theoretical BSC would decrease, which did not match 
qualitatively with the experimental BSC estimate. 
 
Figure 4.13 Experimental estimates of blood BSC for varying PRP amplitudes, and theoretical 
calculation of BSC for varying hematocrits (H), reported as a ratio, and for an aggregate diameter 
of zero 
 After UCAs were added to the blood, estimates of the BSC were acquired using 
both the experimentally obtained BSC of blood and the theoretical calculation for blood 
BSC as references. Attenuation through the UCAs in blood was also estimated using 
the experimentally acquired attenuation estimates for blood as a reference. The results 
for attenuation are presented in Figure 4.14. 
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Figure 4.14 UCA attenuation coefficient estimates using the flow system and the experimental 
attenuation coefficients through blood as references for varying PRP amplitude and a 2x 
concentration of UCAs 
 The two BSC estimates, based upon both the experimental and theoretical blood 
BSC references, are shown in Figure 4.15. The sections where the estimated BSC was 
negative due to poor SNR are not included in the figure. Because neither of these 
estimates matched qualitatively with the predictions of the linear model, these results 
were not used to acquire attenuation estimates. Also, these estimates of attenuation 
and BSC were based upon initial results from two trials. Therefore, the work with UCAs 
in blood has only been a preliminary study. Further work is required to improve 
experimental techniques and acquire accurate estimates. 
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(a) 
 
(b) 
Figure 4.15 Estimated BSC of UCAs at a 2x concentration in blood for varying PRP amplitude, 
using blood as a reference medium, and where (a) the experimental BSC of blood was used as the 
reference BSC or (b) the theoretical BSC of blood was used as the reference BSC 
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4.5 Results for the simulations of the BSC 
 It was desirable to examine the behavior of the nonlinear (Marmottant) model at 
frequencies close to 20 MHz. To do this, the BSC for a volume of randomly located 
UCAs was simulated with the nonlinear model, as outlined in Chapter 3.5. The input 
parameters for the simulation were based upon the results from the Levenberg-
Marquardt algorithm used to fit the experimental BSCs of UCAs in degassed water to 
the linear (de Jong) model. More specifically, these parameters were estimates of the 
mean UCA diameter, standard deviation in diameter, and the UCA concentration. Also, 
the incident PRP amplitude used was 140 kPa because the UCA concentrations 
obtained from the experimental BSCs corresponding to this PRP most closely matched 
the hemacytometer based concentration estimates. Figure 4.16 contains the results of 
the simulated BSCs (Marmottant model) for an incident PRP amplitude of 140 kPa and 
1x, 2x, and 5x concentrations of UCAs, as well as the experimental BSCs for each of 
those cases and the corresponding theoretical curve predicted by the linear (de Jong) 
model. The experimental BSCs for an incident PRP amplitude of 140 kPa were used for 
comparison to the results from the two models. 
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(a) 
 
(b) 
 
 
(c) 
Figure 4.16 Comparison of the two theoretical models for UCA dynamic with the experimental BSC 
estimate using an initial PRP of 140 kPa, and an UCA concentration of (a) 1x, (b) 2x, and (c) 5x  
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CHAPTER 5 DISCUSSION AND FUTURE WORK 
5.1 Introduction 
 In this chapter the results of the four conducted experiments are reviewed and 
discussed in more detail. Then, a brief discussion of the simulation results is included, 
and the implications of the results are analyzed in terms of the scattering models that 
were studied in this work. Finally, the results are summarized and a recommendation for 
further investigations is highlighted. 
5.2 Discussion of experimental results 
5.2.1 Beaker experiments 
 The BSCs in Figure 4.7 vary as a function of depth, indicating a change in the 
concentration of scatterers. A gradient of concentration was established with respect to 
height inside the beaker, which was most likely due to the Plexiglas reflector interfering 
with mixing and the natural buoyancy of the bubbles. This not only affected the 
backscatter measurements acquired from the vertically positioned transducer, but it also 
greatly increased the uncertainty of the hemacytometer based concentration estimates. 
One of the problems with the beaker apparatus, as shown in Figure 3.5, was that the 
hole for insertion and withdrawal of UCAs and degassed water was located away from 
the site from which ultrasonic backscatter data was acquired. This made it possible to 
obtain only an average estimate of concentration in the beaker with the hemacytometer. 
Therefore, the ultrasonic based UCA concentration estimates in Table 4.1 were only 
comparable to the hemacytometer based estimates to within an order of magnitude.  
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  As a result of the design weaknesses of the beaker chamber, the flow system 
was developed. This provided better control of the flow of UCAs across the target site. It 
also allowed for more efficient withdrawal of a sample of UCAs near the actual 
ultrasound measurement site in order to provide accurate confirmation of UCA 
concentration values. 
5.2.2 Flow system experiments 
5.2.2.1 Glass beads in degassed water 
 The experimental BSC from the glass beads matched the curve predicted by 
Faran theory qualitatively between 18 and 28 MHz. These results demonstrated that the 
flow system and the procedure for estimating BSC could be used to make accurate size 
and concentration estimates. For all trials, the ESD estimates were within 2% of 49.5 
µm, the mean estimated diameter of the beads acquired from the microscope images.  
Also, because the ESC estimates were no more than 4% different from the glass bead 
concentration estimates acquired using the water evaporation technique outlined in 
Section 3.4.3.2, the flow system setup was demonstrated to be robust for estimating 
multiple concentrations.  
 When the bead concentration estimates acquired with the water evaporation 
technique were compared to the average estimate based upon the 5 or 10 g of beads 
inserted into the beaker, the water evaporation technique produced estimates that were 
consistently about 20% less than the total concentration of beads in the beaker. This 
indicated that fewer beads were consistently moving through the flow chamber than 
were actually inside the beaker reservoir. This result was useful when the experiments 
with UCAs in degassed water were designed for the flow system; that is, the 
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hemacytometer based estimates of concentration used for these experiments were 
better for verifying the concentration in the flow chamber because these estimates were 
more accurate than estimates based upon the amount inserted (1x, 2x, or 5x 
concentrations).  
 The glass beads were used to determine not only whether the concentration in 
the flow chamber matched the ultrasonic estimates, but also to determine whether the 
concentration was uniform across the channel inside the flow chamber. If more 
scatterers in the chamber were to travel down the middle than the sides, the magnitude 
of the BSC, and subsequently the estimate of concentration, would change as the 
transducer was moved laterally across the scanning window. This would make it much 
more difficult to obtain hemacytometer based concentration estimates for the UCAs 
because the focus of the transducer may not have been directly in line with the location 
where the degassed water and UCA mixture was extracted. To determine if this was 
occurring, the focus of the transducer was moved laterally across the scanning window 
and the corresponding BSC and ESC for the glass beads was estimated. It was found 
that the maximum difference between ESCs across the entire scanning window was 
less than 0.5%; therefore, it was concluded that the flow was approximately uniform 
across the channel. 
5.2.2.2 UCAs in degassed water 
 Many studies [22], [32], [60] have shown that the attenuation of a polydisperse 
volume of UCAs peaks near the resonance frequencies of the UCAs and then 
decreases, which was corroborated by the results in Figure 4.10. One previous study 
[61] estimated the attenuation coefficient of Definity UCAs for a concentration of 200x 
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the dosage recommended by the manufacturer. Their estimated attenuation reached 31 
dB/cm at 30 MHz, which was much higher than previous attenuation estimates [32]. 
These very high estimates of attenuation indicate that future work in vivo must focus on 
accurate techniques for attenuation estimation, so that the BSC can be correctly 
estimated. 
 The hemacytometer based method for estimating UCA concentration was 
significantly better than the method used in previous studies [21], [22] where the 
concentration of UCAs was assumed to be uniform and equal to the amount inserted. 
However, the hemacytometer based estimates still contained some uncertainty due to 
the movement of the UCAs inside the syringe after extraction and inside the chamber as 
well. The buoyancy of the UCAs was noticeable while they were being counted because 
the focal plane of the microscope had to be adjusted slightly over time to account for 
rising of the UCAs. As explained in Section 3.4.1, the estimates were repeated six times 
and were therefore reported with an average and standard deviation in the tables. At 
140 kPa, the ultrasonic based UCA concentration estimates matched the 
hemacytometer based estimates to within one standard deviation for all trials and 
concentrations (Table 4.3). 
 A major advantage of the flow system was that the UCAs were more uniformly 
distributed throughout the system than in the beaker experiments. Also, clustering, 
which can easily occur when the sticky lipid-shelled Definity UCAs are not continuously 
mixed, was prevented through constant flow and mixing in the beaker. As a result, the 
BSC estimates of UCAs in degassed water matched qualitatively well with the 
predictions of the linear de Jong model. In Figure 4.11, however, the BSCs decreased 
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with increasing incident PRP amplitude, which was not predicted by the linear model. 
The decrease in BSC magnitude was most likely due to the effects of nonlinear 
oscillations of UCAs on the BSC. Using Table 4.4, the limits of incident PRP that still 
resulted in UCA concentration estimates within one standard deviation of the 
hemacytometer based concentration estimates were determined to be about 140-390 
kPa. The BSCs in Figure 4.11 were for PRP amplitudes under 400 kPa. However, the 
experimental BSCs acquired using PRP amplitudes higher than 400 kPa were also 
investigated. Figure 5.1 shows the attenuation-compensated, estimated BSC for a 
concentration of 5x the recommended dosage and a PRP amplitude of 520 kPa. 
 
Figure 5.1 Estimated BSC of UCAs in degassed water for two PRPs and a concentration of 5x the 
recommended dosage 
 For higher PRP amplitudes and concentrations, the BSC curve began to rise at 
approximately 22-25 MHz. This behavior was observed for all trials with these 
parameters. A possible explanation for this is as follows. The majority of UCAs have 
resonant frequencies of 6-12 MHz, based upon the estimated size distribution and the 
16 18 20 22 24 26 28
10
-1.6
10
-1.5
10
-1.4
10
-1.3
Frequency (MHz)
B
a
c
k
s
c
a
tt
e
r 
C
o
e
ff
ic
ie
n
t 
((
c
m
*s
r)-
1
)
 
 
PRP = 140 kPa
510 kPa
69 
 
predictions for resonant frequencies of the two models in Figure 2.1 and Figure 2.2. 
Because the 20 MHz pulse from the transducer that was used had a wide bandwidth, 
some of the smaller UCAs with resonant frequencies of about 12 MHz were excited at 
resonance. For substantially high PRP and concentrations of these UCAs, their 
nonlinear oscillations could have produced a strong signal at approximately 25 MHz, the 
second harmonic of their resonant frequency. This would produce an increase in the 
scattered power at 25 MHz, which was observed in these cases. Currently, no model 
that has predicted this behavior is known to the author. In order to avoid bias toward 
higher UCA concentration estimates due to the increasing BSC above 25 MHz, all of the 
concentration estimates that were acquired from the estimated BSCs were obtained 
using a frequency range of 15-25 MHz. 
 The following novel contributions were made as a result of the experiments with 
UCAs in degassed water and the flow system. First, a technique for estimating UCA 
concentration, based upon a Levenberg-Marquardt regression algorithm, was 
developed to minimize the root mean square error between the linear theoretical model 
and the experimental BSC estimates. Second, the optimal range for estimating the UCA 
concentration was determined using the physical properties of the UCA Definity and the 
predictions of the linear scattering model. Third, the ultrasonic based UCA concentration 
estimates were verified using a hemacytometer and a sample of the UCA and degassed 
water mixture that was extracted directly from the chamber where the ultrasonic data 
was collected. This provided more accurate estimates of UCA concentration than if the 
amount inserted into the system was assumed to be correct. Lastly, the importance of 
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restricting the incident PRP amplitude at the target site was demonstrated by acquiring 
concentration estimates for varying PRP amplitude. 
 It is important to note two significant constraints to this technique for estimating 
UCA concentration. First, the frequency range of the BSC from which the concentration 
estimates were extracted was based upon the calculations of theoretical BSC presented 
in Section 2.3.1 and was derived using the properties of Definity UCAs. Other 
commonly used UCAs, which are made of different shell and gas combinations, often 
have mean diameters that are lower than the mean diameter of Definity UCAs. Because 
larger UCAs tend to have lower resonance frequencies, a lower frequency range than 
the 15-25 MHz used for Definity may be more practical. Also, shell properties can 
significantly affect the resonance frequencies, and so the calculation of theoretical 
BSCs is necessary for determining an optimal frequency range. The second constraint 
of the UCA concentration estimation technique is due to the convergence of the 
Levenberg-Marquardt algorithm. As detailed in Section 3.4.4, the limitations of the 
estimation technique are due to the three initial parameters, which are the variables that 
were estimated by the algorithm. The two size distribution parameters did not limit the 
convergence of the algorithm as long as the initial estimates were within the limits of the 
size distribution parameter estimates for Definity. However, the algorithm could not 
converge when the initial UCA concentration was greater than 100 times different than 
the final value. As a result, if future experiments were conducted with concentrations 
100 times greater than the 1x dosage, it would be necessary to have some knowledge 
of the final concentration in order for the algorithm to converge. This must be 
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considered when investigations are conducted in vivo, where concentrations can vary 
greatly among target locations. 
5.2.2.3 UCAs in blood 
 Attenuation estimates that were acquired with the flow system for higher PRP 
amplitudes did match previous estimates for attenuation slope in the literature at a 
shear rate of 5 s-1. However, two observations were made. First, although the slope of 
the attenuation coefficient matched previous results, the magnitude of the attenuation 
was lower. A possible explanation for this is that the previous estimates of attenuation in 
whole blood were based upon a hematocrit of 40%. Although the hematocrit was not 
determined for the blood samples used in the flow system experiments, it is possible 
that a different blood hematocrit was used, which could correspond to a different 
magnitude of the attenuation coefficient. The second observation was that the 
attenuation estimate acquired with a PRP amplitude of 270 kPa was lower in magnitude 
than the estimates acquired with higher PRPs, and the estimate matched the slope of 
the estimates in the literature for faster shear rates. During the experiments with blood 
in the flow system, a higher level of noise was observed. The SNR of the data acquired 
with a PRP of 270 kPa was lower than the SNR of the data acquired with higher PRPs. 
This may have resulted in an inaccurate estimate for the lower PRP. Also, the 
attenuation estimates reported in the literature were assumed to be linear with 
frequency and averaged over many trials. This could have created a bias toward linear 
estimates of attenuation because the data was fit to a linear model. 
 The estimates for the BSC of blood reported in Figure 4.13 reflect the low SNR 
that affected the data for all PRP amplitudes. Below 18 MHz, the power spectra of the 
72 
 
blood backscatter were below the noise floor; therefore, the BSCs were only reported 
above 18 MHz. The overall slope of the estimated BSCs was greater than that predicted 
by the theoretical model for blood BSC, even when the aggregation of blood was 
ignored. When the hematocrit was increased, the theoretical BSC decreased. It was 
therefore likely that the porcine whole blood that was used had a lower hematocrit. 
 When the attenuation estimates of the UCAs, using blood as the reference, were 
compared to those acquired in water, the results were quite different. The magnitude of 
the estimated attenuation of UCAs in blood was almost double the magnitude of the 
estimates for UCAs in water. Also, for UCAs in blood, the attenuation estimates 
increased with increasing frequency. These estimates do not match those obtained for 
UCAs in previous studies, as do the estimates acquired from UCAs in water. Finally, the 
attenuation estimates for UCAs were approximately the same for a PRP amplitude of 
390 kPa and 510 kPa. This does not agree with the experimental results or with 
previous studies [32]. The attenuation estimate acquired with a PRP amplitude of 270 
kPa was the lowest estimate, which was consistent with the results from the 
experiments with UCAs in degassed water. However, this could have been because the 
experimental attenuation estimate for blood using a PRP amplitude of 270 kPa was 
lower than the estimates for blood with higher PRP amplitudes. Therefore, the 
attenuation estimates will need to be repeated more carefully in the future in order to 
acquire accurate estimates. 
 The estimates of the BSC of UCAs in blood did not match qualitatively with the 
theoretical predictions for the BSC of UCAs with the linear model. The estimated BSC 
that was obtained using the experimental BSC of blood as a reference had a large 
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positive slope with respect to frequency, rather than the small negative slope predicted 
by the model. As a result, the linear scattering model for UCAs was not used to extract 
concentration estimates. Also, hemacytometer based estimates of UCA concentration in 
blood could not be obtained. The RBCs covered the UCAs and made it difficult to see 
and count the UCAs under the microscope. In the future, alternative methods for 
verifying UCA concentrations in blood must be devised. 
 The overall magnitude of the BSC estimates of UCAs in blood was much greater 
than the magnitude of the BSC estimates for the same 2x concentration of UCAs in 
water. One possible explanation for the large positive slope and magnitude difference is 
the way the estimate of BSC was calculated. In order to obtain the BSC, the ratio of the 
backscattered power from UCAs in blood to the backscattered power from blood alone 
was computed. However, the backscattered power from the blood alone had a very 
poor SNR, as evidenced by the negative values in the power spectrum after the noise 
spectrum was subtracted and the resulting experimental BSC estimates for blood. If the 
power spectrum from the blood alone was mostly due to averaging of noise fluctuations, 
computing the ratio of the power spectra was equivalent to dividing the power spectrum 
from UCAs in blood by low magnitude values and noise. This amplified the magnitude of 
the noise, causing the estimate of BSC to be inaccurate and large in magnitude. Before 
the estimates for the BSC of UCAs in blood can be used to extract UCA concentration 
estimates, methods to improve the estimation of the power spectrum from blood and the 
corresponding SNR need to be devised. 
 The procedure used to estimate the BSC of UCAs in blood was based upon the 
assumption that the backscattered power from UCAs alone is much greater than the 
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backscattered power from blood alone. To examine the validity of this assumption, 
previous results for BSCs of porcine whole blood [46], as well as the results for blood 
BSC estimates obtained in the flow system experiments, were compared to the results 
obtained for the BSC of UCAs in degassed water. The BSC of porcine whole blood [46] 
with a 40% hematocrit is shown in Figure 5.2.  
 
Figure 5.2 From [46], the estimated BSC for porcine whole blood at 40% hematocrit (H40), 40% 
hematocrit and a shear rate of 100 s
-1
 (T40-RS100), and the predictions of their theoretical model 
 The BSC was approximately 10-3.1 1/cm/sr in [46] and 10-1 1/cm/sr at 25 MHz. By 
contrast, the BSC of UCAs at a concentration of 1x is approximately 10-2.1 at 25 MHz. 
Using the results from [46], the BSC of UCAs was greater than ten times the BSC of 
blood alone in the frequency range of 15-25 MHz. Therefore, the assumption is valid. 
However, if the estimates of the BSC of blood from the flow system experiments are 
accurate (Figure 4.15), the assumption is no longer valid. Future work must focus on 
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better estimation of the BSC of blood in order to determine if the assumption is valid for 
the frequency range of 15-25 MHz. 
 A few more suggestions for future work with this technique for estimating UCA 
concentration in blood are provided. First, the most significant reason for the inaccurate 
estimates of attenuation and BSC of UCAs in blood was the poor SNR that was 
achieved for the PRP amplitudes that were used. Because this technique for estimating 
UCA concentration requires low PRP amplitudes for the linear model to be used to 
acquire estimates, it will be necessary to maintain in situ PRP amplitudes of at most 510 
kPa in future work. Therefore, other techniques for increasing the SNR without 
increasing the PRP amplitude must be explored. Also, the hemacytometer was not fit for 
extracting optical estimates of UCA concentration in blood, as reported above. 
Therefore, a technique for verifying ultrasound based UCA concentration estimates 
must be developed. Finally, a method for obtaining the hematocrit of the blood samples 
that were used will need to be implemented. 
5.3 Discussion of the simulation and scattering models 
 Referring to Figure 4.16, the nonlinear Marmottant model did not predict the 
shape of the experimental BSC for a PRP of 140 kPa and frequencies above 20 MHz. 
The slope of the simulated BSC based upon the Marmottant model was more negative 
than that of the experimental BSC and corresponding theoretical predictions of the 
linear model. Although the BSCs were similar for lower frequencies, which were closer 
to the resonance frequencies of most of the UCAs, the magnitude of the backscattered 
power from the oscillating UCAs in the simulation decreased significantly above 20 
MHz.  
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 It is hypothesized that for the properties of Definity and the simulated 
experimental conditions, the scattered power from UCAs excited above 20 MHz is 
dominated by the size of the UCAs rather than their movement. Therefore, the 
Marmottant model would be better for predicting the scattered power from UCAs 
oscillating with large amplitudes close to their resonance frequencies, and the linearized 
de Jong model would be more suitable for predicting the BSC when an UCA is excited 
at frequencies much higher than its resonance frequency. Another possible explanation 
for the lack of agreement between the simulated and experimental data was that the 
model does not incorporate the effect of frequency dependent shell properties. Goertz 
et al. [32] observed that the shell dilatational viscosity term, κs, for Definity was both 
frequency and size dependent. In fact, they found that shell viscosity decreased for 
increasing UCA diameter. Also, they concluded that small Definity UCAs undergo 
substantially more nonlinear oscillations at higher frequencies than other UCA types of 
similar size. 
 One of the caveats of using the linear model was the assumption of linear 
oscillations. Because the nonlinear Marmottant model, introduced in Section 2.3.2, was 
designed to predict the occurrence of nonlinear oscillation more accurately than other 
previously derived nonlinear models, it was used to determine the limit of PRP 
amplitude above which nonlinear oscillations were present. The scattered pressure from 
a 2.2-µm UCA was simulated using a 20-MHz Gaussian pulse with a fractional 
bandwidth of 80%, parameters for Definity, and PRP amplitudes from 5 to 1000 kPa in 5 
kPa increments. Three types of results were discovered. First, for PRP amplitudes 
below 20 kPa, the maximum peak occurred at about 8 MHz, close to the resonance 
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frequency of the 2.2 µm diameter UCA based upon the Marmottant formulation. 
Second, for PRP amplitudes between 20 kPa and 65 kPa, the magnitude of the first 
harmonic at 20 MHz dominated, and no visible second harmonic peaked within 60 dB of 
the first harmonic. Finally, for PRP amplitudes above 65 kPa, the spectrum contained a 
visible second harmonic that increased as PRP amplitude increased. Examples of these 
three cases are shown in Figure 5.3. 
 
Figure 5.3 Simulation results for scattered pressure from a 2.2-µm UCA excited with a 20 MHz 
center frequency Gaussian pulse for varying PRP amplitude, normalized to the peak at 20 MHz 
 For comparison, the PRP amplitudes used in the experiments with UCAs from 
this work ranged from about 70 to 500 kPa, and the linear model was used to make 
UCA concentration estimates that were within one standard deviation of the 
hemacytometer based estimates for all trials using PRP amplitudes of about 140-390 
kPa. Although these pressures are above the 65 kPa limit for nonlinear oscillations 
predicted by the Marmottant model, the magnitude of the second harmonic for an 
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incident PRP of 400 kPa, calculated using the model, was 40 dB down from the peak at 
20 MHz. At this incident PRP level, the magnitude of the scattered pressure due to 
nonlinear oscillations was one hundredth the scattered pressure from the first harmonic. 
Therefore, the effects from nonlinear oscillations were not significant enough to cause 
large deviations from the predictions of the linear model.  
 The onset of nonlinear oscillations has also been investigated for other UCA 
types and frequency ranges [35], [62]. De Jong et al. [35] reported that the scattered 
pressure from coated UCAs has been observed to contain energy in higher harmonics 
for incident PRP amplitudes as low as 20-50 kPa. They conducted an experiment with 
Sonovue (Bracco, Milan, Italy) UCAs insonated at 3.5 MHz for varying incident PRP 
amplitudes. Second harmonic energy was observed above the noise floor for a 
minimum incident PRP amplitude of 24 kPa. Qin et al. [62], on the other hand, cited a 
nonlinear model and the experimental work from previous studies and used the 
predicted radius versus time curves from the model to estimate the onset of nonlinear 
oscillations. They reported that a 2-µm-diameter UCA insonated at 1 MHz will exhibit 
nonlinear oscillatory behavior for incident PRPs of at least 150 kPa. However, the 
results from these previous studies were performed using excitation frequencies less 
than 10 MHz. No previous work has been done to determine the onset of nonlinear 
oscillations for excitation frequencies close to 20 MHz. 
 If the assumption of linear oscillations is no longer valid, UCA concentration 
estimates using the linear model may be inaccurate. However, nonlinear oscillations are 
more prevalent when a UCA is excited at or near its resonant frequency. With this 
technique for estimation of UCA concentration, the UCAs are excited above their 
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resonant frequencies, and therefore, the pressure threshold above which nonlinear 
oscillations dominate is higher for these frequencies than for resonant excitation 
frequencies. As a result, the UCA concentration estimates acquired using the technique 
presented in this work should remain accurate for higher PRP amplitudes. 
5.4 Conclusions 
 In this work a noninvasive technique for estimating the concentration of UCAs in 
vitro was developed, using a linearized theoretical model for scattering from UCAs. 
Estimates of UCA concentration in degassed water were obtained by fitting the 
estimated BSC to the linearized theoretical model in the frequency range of 15-25 MHz. 
The technique was verified for the experiments in degassed water with hemacytometer 
based estimates obtained by the withdrawal of the UCA and water mixture from the 
system. Results indicated that the experimental setup and technique were successful 
for estimating both glass bead and UCA concentrations in degassed water within the 
limits of the pressure amplitudes used in the experiments. Ultrasonic based estimates of 
UCA concentration were within one standard deviation of the hemacytometer based 
concentration estimates for incident PRP amplitudes of 140-390 kPa. 
 The results for the four conducted experiments are summarized as follows. UCA 
concentration estimates acquired from the beaker experiments with UCAs in degassed 
water showed that UCA concentration varied with depth, such that the concentration of 
UCAs increased with increasing height in the beaker. Due to this concentration gradient, 
it was difficult to verify the concentration estimates with the hemacytometer. In order to 
eliminate this problem, the second and third experiments were conducted in the flow 
system that was developed. For these experiments, concentration estimates of glass 
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beads and UCAs in degassed water were obtained by estimating the BSC using 
pulse/echo ultrasound. The concentration estimates of the glass beads were verified 
using a water evaporation technique to separate and estimate the mass of beads in the 
system. Both these estimates of glass bead concentration and the hemacytometer 
based estimates of UCA concentration indicated that the ultrasound based 
concentration estimation technique was successful using the flow system with degassed 
water. Finally, initial experiments were conducted to estimate the BSC of UCAs using 
blood as a reference medium in the flow system. Results indicated that further work will 
be required to refine the concentration estimation technique and the verification process 
so that the technique can be extended to in vivo applications. 
 In order to be able to obtain UCA concentration estimates at a target site in vivo, 
further investigation of the ultrasound based UCA concentration estimation technique is 
required. The technique depends upon the use of a model for small UCA oscillations, 
which limits the range of incident PRP amplitudes that can be used to produce accurate 
results. The ability to estimate the PRP amplitude in vivo would ensure the accuracy of 
the UCA concentration estimates. Further studies could then be used to determine the 
relationship between the in vivo PRP estimates and common clinical parameters such 
as the mechanical index (MI). For example, one recent study estimated UCA 
destruction in vivo by varying the concentrations of UCAs in µL/kg via bolus injections 
and by varying the MI within clinical limits [63]. By relating the destruction of UCAs to MI 
and the concentrations of bolus injections, the authors created a method for estimating 
UCA destruction that can be easily implemented in the clinic. It is recommended that 
further studies be conducted to provide guidelines for the UCA concentrations and 
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common clinical parameters such as MI that can be used to acquire accurate UCA 
concentration estimates. 
 One advantage of using the blood itself as a reference in vivo, as was outlined 
for in vitro work in Section 3.4.3, is the ability to acquire UCA concentration estimates 
without the need for estimation of the intervening tissue transmission and attenuation 
losses. In the in vitro work presented here, an insertion loss method was used with a 
Plexiglas reflector as the reference. The attenuating medium was placed between the 
ultrasound transducer and the reflector so that the reflected waves could be compared 
with and without the medium. For in vivo work, however, it is not feasible to use this 
technique due to the need for a plane reflector inside the tissue. Therefore, a new 
method for estimating the attenuation for each trial is vital to be able to accurately 
estimate the BSC of UCAs in vivo. This could occur through estimating both UCA 
concentration and attenuation from the backscatter. 
 Finally, as was emphasized in Section 1.2, the concentrations of UCAs that have 
been shown to enhance ultrasound based therapeutic techniques are much higher than 
those currently used for imaging (a 1x concentration of Definity for imaging is about 
9.6x105 UCAs/mL, as recommended by the manufacturer). The assumption used to 
derive the BSC with the linear model was that minimal multiple scattering was occurring. 
This corresponds to a linear relationship between UCA concentration and backscattered 
power, which was previously found to hold for concentrations up to 2x107 UCAs/mL, or 
about 20 times the recommended concentration for imaging [20]. However, because 
concentrations may vary by the type of injection and by the type of tissue in vivo, it is 
probable that UCA clouds with very high concentrations will be present in some 
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locations. Effects of UCA interactions cannot be neglected for these high 
concentrations, as was done for the derivation of the BSC with the linear model in this 
work. In fact, one study found that the pressure threshold for UCA destruction increased 
significantly for very high UCA concentrations [64]. Therefore, an in vivo implementation 
of the UCA concentration estimation technique would require further studies of the 
relationship between backscattered power and UCA clouds with higher concentrations 
to include the effects of multiple scattering and possible UCA interactions. Each of these 
suggestions for further investigation will be useful for the extraction of UCA 
concentration estimates to be extended to in vivo applications.  
83 
 
 
REFERENCES 
[1] M. Averkiou, J. Powers, D. Skyba, M. Bruce, and S. Jensen, “Ultrasound contrast 
 imaging research,” Ultrasound Quarterly, vol. 19, pp. 27-37, 2003.  
[2] D. Cosgrove and C. Harvey, “Clinical uses of microbubbles in diagnosis and 
 treatment,” Medical and Biological Engineering and Computing, vol. 47, pp. 813-
 826, 2009. 
[3]  H. Becker and P. Burns, Handbook of Contrast Echocardiography, Heidelberg, 
Germany: Springer-Verlag, 2000, pp. 82-83. 
[4] D. L. Miller and C. Dou, “Membrane damage thresholds for pulsed or continuous 
ultrasound in phagocytic cells loaded with contrast agent gas bodies,” Ultrasound 
in Medicine and Biology, vol. 30, pp. 405-411, 2004. 
[5]  D. L. Miller, C. Dou, and R. C. Wiggins, “Frequency dependence of kidney injury 
induced by contrast-aided diagnostic ultrasound in rats,” Ultrasound in Medicine 
and Biology, vol. 34, pp. 1678-1687, 2008. 
[6] D. M. Skyba R. J. Price, A. Z. Linka, T. C. Skalak, and S. Kaul, “Direct in vivo 
visualization of intravascular destruction of microbubbles by ultrasound and its 
local effects on tissue,” Circulation, vol. 98, pp. 290-293, 1998. 
[7] R. Bekeredjian, P. A. Grayburn, and R. V. Shohet, “Use of ultrasound contrast 
agents for gene or drug delivery in cardiovascular medicine,” Journal of the 
American College of Cardiology, vol. 45, pp. 329-225, 2005. 
[8]  Z. Fan, R. E. Kumon, J. Park, and C. X. Deng, “Intracellular delivery and calcium 
transients generated in sonoporation facilitated by microbubbles,” Journal of 
Controlled Release, vol. 142, pp. 31-39, 2010. 
[9] M. M. Forbes, R. L. Steinberg, and W. D. O'Brien Jr., “Frequency-dependent 
evaluation of the role of Definity in producing sonoporatior of Chinese hamster 
ovary cells,” Journal of Ultrasound in Medicine, vol. 30, pp. 61-69, 2011. 
[10] E. Kimmel, “Cavitation bioeffects,” Critical Reviews in Biomedical Engineering, 
vol. 34, pp. 105-161, 2006. 
[11] C. A. Johnson, S. Sarwate, R. J. Miller, and W. D. O‟Brien Jr, “A temporal study 
of ultrasound contrast agent-induced changes in capillary density,” Journal of 
Ultrasound in Medicine, vol. 29, pp. 1267-1275, 2010. 
[12] M. R. Bailey et al., “Cavitation detection during shock-wave lithotripsy,” 
Ultrasound in Medicine and Biology, vol. 31, pp. 1245-1256,  2005. 
84 
 
 
[13] E. P. Stride and C. C. Coussios, “Cavitation and contrast: The use of bubbles in 
ultrasound imaging and therapy,” Proceedings of the Institution of Mechanical 
Engineers, Part H: Journal of Engineering in Medicine, vol. 224, pp. 171-191, 
2010. 
[14]  W. Luo et al., “Ablation of high-intensity focused ultrasound assisted with 
SonoVue on rabbit VX2 liver tumors: Sequential findings with histopathology, 
immunohistochemistry, and enzyme histochemistry,” Annals of Surgical 
Oncology, vol. 16, pp. 2359-2368, 2009. 
[15] F. Li and L. Fu, “Using microbubble contrast agent of different dosage to 
enhancing liver ablation induced by high-intensity focused ultrasound,” in IFMBE 
Proceedings, vol. 25, 2009, pp. 39-42. 
[16] T. Nishihara, H. Utashiro, M. Ichiyanagi, K. Yoshinaka, S. Takagi, and Y. 
Matsumoto, “Heating location control of HIFU treatment enhanced with 
microbubbles contrast agents,” in IFMBE Proceedings, vol. 31, 2010, pp. 1397-
1400. 
[17] D. A. B. Smith et al., “Ultrasound-triggered release of recombinant tissue-type 
plasminogen activator from echogenic liposomes,” Ultrasound in Medicine and 
Biology, vol. 36, pp. 145-157, 2010. 
[18] J. R. Eisenbrey, M. C. Soulen, and M. A. Wheatley, “Delivery of encapsulated 
doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer 
contrast agents,” IEEE Transactions on Biomedical Engineering, vol. 57, pp. 24-
28, 2010. 
[19] D. W. Droste. “Clinical utility of contrast-enhanced ultrasound in neurosonology.” 
European Neurology, vol. 59, pp. 2-8, 2008. 
[20] M. Lampaskis and M. Averkiou, “Investigation of the relationship of nonlinear 
backscattered ultrasound intensity with microbubble concentration at low MI,” 
Ultrasound in Medicine and Biology, vol. 36, pp. 306-312, 2010. 
[21] C. M. Moran, R. J. Watson, K. A. A. Fox, and W. N. McDicken, “In vitro acoustic 
characterization of four intravenous ultrasound contrast agents at 30 MHz,” 
Ultrasound in Medicine and Biology, vol. 28, pp. 785-791, 2002. 
[22] J. N. Marsh et al. “Frequency and concentration dependence of the backscatter 
coefficient of the ultrasound contrast agent Albunex,” Journal of the Acoustical 
Society of America, vol. 104, pp. 1654-1666, 1998. 
[23] J. J. Faran, “Sound scattering by solid cylinders and spheres,” Journal of the 
Acoustical Society of America, vol. 24, pp. 405-418, 1951. 
85 
 
 
[24] M. F. Insana and T. J. Hall, “Parametric ultrasound imaging from backscatter 
coefficient measurements: image formation and interpretation,” Ultrasonic 
Imaging, vol. 12, pp. 245-267, 1990. 
[25] R. J. Lavarello, G. Ghoshal, and M. L. Oelze, “On the estimation of backscatter 
coefficients using single element focused transducers,” Journal of the Acoustical 
Society of America, vol. 129, pp. 2903-2911, 2011. 
[26] R. S. C. Cobbold, Foundations of Biomedical Ultrasound, Oxford, UK: Oxford 
University Press, 2006. 
[27] R. Wildt, “Acoustic theory of bubbles,” US Navy, Physics of Sound in the Sea, 
NDRC Summary, Technical Report Division 6, vol. 8, 1946. 
[28] N. de Jong, L. Hoff, T. Skotland, and N. Bom, “Absorption and scatter of 
encapsulated gas filled microspheres: theoretical considerations and some 
measurements,” Ultrasonics, vol 30, pp. 95-103, 1992. 
[29] H. Medwin, “Counting bubbles acoustically: a review,” Ultrasonics, vol. 15, pp. 7-
13, 1977. 
[30] N. de Jong and L. Hoff, “Ultrasound scattering properties of Albunex 
 microspheres,” Ultrasonics, vol. 31, pp. 175-181, 1993. 
[31] J. Gorce, M. Arditi, and M. Schneider, “Influence of bubble size distribution on the 
echogenicity of ultrasound contrast agents: a study of Sonovue™,” Investigative 
Radiology, vol. 35, pp. 661-671, 2000. 
[32] D. E. Goertz, N. de Jong, and A.F. van der Steen, “Attenuation and size 
distribution measurements of Definity and manipulated Definity populations,” 
Ultrasound in Medicine and Biology, vol. 33, pp. 1376-1388, 2007. 
[33] T. Faez, D. Goertz, and N. de Jong, “Characterization of Definity ultrasound 
contrast agent at frequency range of 5-15 MHz,” Ultrasound in Medicine and 
Biology, vol. 37, pp. 338-342, 2010. 
[34] P. Marmottant et al., “A model for large amplitude oscillations of coated bubbles 
accounting for buckling and rupture,” Journal of the Acoustical Society of 
America, vol. 118, pp. 3499-3505, 2005. 
[35] N. de Jong, M. Emmer, A. van Wamel, and M. Versluis, “Ultrasonic 
 characterization of ultrasound contrast agents,” Medical and Biological 
 Engineering and Computing, vol. 47, pp. 861-873, 2009. 
86 
 
 
[36] D. A. King and W. D. O‟Brien Jr., “Comparison between maximum radial 
expansion of ultrasound contrast agents and experimental postexcitation signal 
results,” Journal of the Acoustical Society of America, vol 129, 114-121, 2011. 
[37] M. Overvelde et al. “Nonlinear shell behavior of phospholipid-coated 
microbubbles,” Ultrasound in Medicine and Biology, vol. 36, pp. 2080-2092, 
2010. 
[38] J. Sijl et al., “Acoustic characterization of single ultrasound contrast agent 
microbubbles,” Journal of the Acoustical Society of America, vol. 124, pp. 4091-
4097, 2008. 
[39] J. Sijl et al., “Subharmonic behavior of phospholipid-coated ultrasound contrast 
agent microbubbles,” Journal of the Acoustical Society of America, vol. 128, pp. 
3239-3252, 2010. 
[40] K. K. Shung, R. A. Sigelmann, and J. M. Reid, “Scattering of ultrasound by 
blood,” IEEE Transactions on Biomedical Engineering, vol. 23, pp. 460-467, 
1967. 
[41] C. Coussios, “The significance of shape and orientation in single-particle weak-
scatterer models,” Journal of the Acoustical Society of America, vol. 112, pp. 
906-915, 2002. 
[42] D. Savéry and G. Cloutier, “High-frequency ultrasound backscattering by blood: 
analytical and semianalytical models of the erythrocyte cross section,” Journal of 
the Acoustical Society of America, vol. 121, pp. 3963-3971, 2007. 
[43] S. Wang and K. K. Shung, “An approach for measuring ultrasonic backscattering 
from biological tissues with focused transducers,” IEEE Transactions on 
Biomedical Engineering, vol. 44, pp. 549-554, 1997. 
[44] L. Mo, I-Y. Kuo, K. K. Shung, L. Ceresne, and R. S. C. Cobbold, “Ultrasound 
scattering from blood with hematocrits up to 100%,” IEEE Transactions on 
Biomedical Engineering, vol. 41, pp. 91-95. 
[45] E. Franceschini, F. T. H. Yu, and G. Cloutier, “Simultaneous estimation of 
attenuation and structure parameters of aggregated red blood cells from 
backscatter measurements,” Journal of the Acoustical Society of America: 
Express Letters, vol. 123, pp. EL85-EL91, 2008. 
[46] F. T. H. Yu and G. Cloutier, “Experimental ultrasound characterization of red 
blood cell aggregation using the structure factor size estimator,” Journal of the 
Acoustical Society of America, vol. 122, pp. 645-656, 2007. 
87 
 
 
[47] M. L. Oelze, W. D. O‟Brien Jr., J. P. Blue, and J. F. Zachary, “Differentiation and 
characterization of rat mammary fibroadenomas and 4T1 mouse carcinomas 
using quantitative ultrasound imaging,” IEEE Transactions on Medical Imaging, 
vol. 23, pp. 764-771, 2004. 
[48]  M. O‟Donnell and J. G. Miller, „„Quantitative broadband ultrasonic backscatter: An 
approach to nondestructive evaluation in acoustically inhomogeneous materials,‟‟ 
Journal of Applied Physics, vol. 52, pp. 1056–1065, 1981. 
[49]  M. L. Oelze and W. D. O'Brien Jr., “Frequency dependent attenuation-
compensation functions for ultrasonic signals backscattered from random media.” 
Journal of the Acoustical Society of America, vol. 111, pp. 2308-2319, 2001. 
[50] D. A. King and W. D. O‟Brien Jr., “Comparison between maximum radial 
expansion of ultrasound contrast agents and experimental postexcitation signal 
results,” Journal of the Acoustical Society of America, vol. 129, pp. 114-121, 
2011. 
[51] P. A. Dayton, K. E. Morgan, A. L. Klibanov, G. H. Brandenburger, and K. E. 
 Ferrara, “Optical and acoustical observations of the effects of ultrasound on 
 contrast agents,” IEEE Transactions on Ultrasonics, Ferroelectrics, and 
 Frequency Control, vol. 46, pp. 220-232, 1999. 
[52] A. Haak, R. Lavarello, and W. D. O‟Brien Jr.,  “Semiautomatic detection of 
 microbubble ultrasound contrast agent destruction applied to Definity using 
 support vector machines,” in Proceedings – IEEE Ultrasonics Symposium, 2007, 
 pp. 660-663.  
[53] M. Mleczko and G. Schmitz, “A method for the determination of the inertial 
 cavitation threshold of ultrasound contrast agents,” in Proceedings – IEEE 
 International Ultrasonics Symposium, 2008, pp.1686-1689.  
[54] E. Franceschini, F. T. H. Yu, F. Destrempes, and G. Cloutier, “Ultrasound 
 characterization of red blood cell aggregation with intervening attenuating tissue-
 mimicking phantoms,” Journal of the Acoustical Society of America, vol. 127, pp. 
 1104-115, 2010. 
[55] K. Levenberg, “A method for the solution of certain non-linear problems in least 
 squares,” Quarterly of Applied Mathematics, vol. 2, pp. 164-168, 1944. 
[56] D. Marquardt, "An algorithm for least-squares estimation of nonlinear 
 parameters," SIAM Journal of Applied Mathematics, vol. 11, pp. 431–441, 1963. 
[57] J. A. Jensen and N. B. Svendsen, “Calculation of pressure fields from arbitrarily 
 shaped, apodized, and excited ultrasound transducers,” IEEE Transactions on 
 Ultrasonics, Ferroelectrics, and Frequency Control, vol. 39, pp. 262-267, 1992. 
88 
 
 
[58] J. A. Jensen, “A program for simulating ultrasound systems,” in Proceedings of 
 the 10th Nordic-Baltic Conference on Biomedical Imaging, 1996, pp. 351-353. 
[59] S. Hilgenfeldt, D. Lohse, and M. Zomack, “Response of bubbles to diagnostic 
 ultrasound: a unifying theoretical approach,” The European Physical Journal B, 
 vol. 4, pp. 247-255, 1998. 
[60] D. Chatterjee, K. Sarkar, P. Jain, and N. E. Schreppler, “On the suitability of 
 broadband attenuation measurement for characterizing contrast agent 
 microbubbles,” Ultrasound in Medicine and Biology, vol. 31, pp. 781-786, 2005. 
[61] S. Stapleton et al., “Acoustic and kinetic behavior of Definity in mice exposed to 
 high frequency ultrasound,” Ultrasound in Medicine and Biology, vol. 35, pp. 296-
 307, 2009. 
[62] S. Qin, C. S. Caskey, and K. W. Ferrara, “Ultrasound contrast microbubbles in 
 imaging and therapy: physical principles and engineering,” Physics in Medicine 
 and Biology, vol. 54, pp. R27-R57, 2009. 
[63] S.-H. Hung, C.-K. Yeh, T.-H. Tsai, T. Chen, and R.-C. Chen, “A simple method 
 for quantifying ultrasound-triggered microbubble destruction,” Ultrasound in 
 Medicine and Biology, vol. 37, pp. 949-957, 2011. 
[64] K. Yasui, J. Lee, T. Tuziuti, A. Towata, T. Kozuka, and Y. Lida, “Influence of the 
 bubble-bubble interaction on destruction of encapsulated microbubbles under 
 ultrasound,” Journal of the Acoustical Society of America, vol. 126, pp. 973-982, 
 2009. 
